Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Ведение взрослых пациентов с врожденными пороками сердца

Список зарубежной литературы

  1. ACC/AHA Task Force on Practice Guidelines. Manual for ACC/AHA Guideline Writing Committees: Methodologies and Policies from the ACC/AHA Task Force on Practice Guidelines. 2006. Available at http://www. acc. org/qualityandscience/clincial/manual/pdfs/methodology. pdf and http://circ. ahajournals. org/manual/. Accessed January 30, 2008.
  2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age dis- tribution. Circulation. 2007;115:163–72.
  3. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37:1170 – 5.
  4. Child JS, Collins-Nakai RL, Alpert JS, et al. Task force 3: workforce description and educational requirements for the care of adults with con- genital heart disease. J Am Coll Cardiol. 2001; 37:1183–7.
  5. Webb GD, Williams RG. Care of the adult with congenital heart disease: introduction. J Am Coll Cardiol. 2001; 37:1166.
  6. Beller GA, Bonow RO, Fuster V. ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement). J Am Coll Cardiol. 2008;51:335 – 8.
  7. Deleted in proof.
  8. Reid GJ, Irvine MJ, McCrindle BW, et al. Prevalence and correlates of suc- cessful transfer from pediatric to adult health care among a cohort of young adults with complex congenital heart defects. Pediatrics. 2004; 113: e197– e205.
  9. Fernandes SM, Landzberg MJ. Transitioning the young adult with con- genital heart disease for life-long medical care. Pediatr Clin North Am. 2004; 51:1739–48.
  10. Skorton DJ, Garson A Jr, Allen HD, et al. Task force 5: adults with con- genital heart disease: access to care. J Am Coll Cardiol. 2001; 37: 1193–8.
  11. Kantoch MJ, Collins-Nakai RL, Medwid S, Ungstad E, Taylor DA. Adult patients’ knowledge about their congenital heart disease. Can J Cardiol. 1997;13:641–5.
  12. Moons P, De Volder E, Budts W, et al. What do adult patients with congenital heart disease know about their disease, treatment, and prevention of com- plications? A call for structured patient education. Heart. 2001; 86:74–80.
  13. State MW, Perloff JK. Psychiatric and psychosocial disorders. In: Perloff JK, Child JS, editors. Congenital Heart Disease in Adults. W. B. Saunders, 1998:227–35.
  14. Kokkonen J, Paavilainen T. Social adaptation of young adults with con- genital heart disease. Int J Cardiol. 1992; 36:23–9.
  15. Linde LM, Rasof B, Dunn OJ. Longitudinal studies of intellectual and behavioral development in children with congenital heart disease. Acta Paediatr Scand. 1970; 59:169 –76.
  16. Goldberg S, Simmons RJ, Newman J, Campbell K, Fowler RS. Congenital heart disease, parental stress, and infant-mother relationships. J Pediatr. 1991; 119: 661– 6.
  17. DeMaso DR, Campis LK, Wypij D, Bertram S, Lipshitz M, Freed M. The impact of maternal perceptions and medical severity on the adjustment of children with congenital heart disease. J Pediatr Psychol. 1991; 16:137– 49.
  18. Baer PE, Freedman DA, Garson A Jr. Long-term psychological follow-up of patients after corrective surgery for tetralogy of Fallot. J Am Acad Child Psychiatry. 1984; 23:622–5.
  19. Brandhagen DJ, Feldt RH, Williams DE. Long-term psychologic implica- tions of congenital heart disease: a 25-year follow-up. Mayo Clin Proc. 1991; 66:474 – 9.
  20. Garson A Jr, Williams RB Jr, Reckless J. Long-term follow-up of patients with tetralogy of Fallot: physical health and psychopathology. J Pediatr. 1974; 85:429 – 33.
  21. Utens EM, Verhulst FC, Meijboom FJ, et al. Behavioural and emotional problems in children and adolescents with congenital heart disease. Psychol Med. 1993; 23:415–24.
  22. Moons P, Van Deyk K, De Blesser L, et al. Quality of life and health status in adults with congenital heart disease: a direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil. 2006; 13:407–13.
  23. Wypij D, Newburger JW, Rappaport LA, et al. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevel- opment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003; 126:1397– 403.
  24. Bellinger DC, Wypij D, duDuplessis AJ, et al. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003; 126:1385–96.
  25. Bellinger DC. Cardiac surgery and the brain: differences between adult and paediatric studies. Heart. 2003; 89:365– 6.
  26. Wernovsky G, Stiles KM, Gauvreau K, et al. Cognitive development after the Fontan operation. Circulation. 2000; 102:883–9.
  27. Forbess JM, Visconti KJ, Hancock-Friesen C, Howe RC, Bellinger DC,Jonas RA. Neurodevelopmental outcome after congenital heart sur- gery: results from an institutional registry. Circulation. 2002; 106:I95–102.
  28. Hovels-Gurich HH, Konrad K, Wiesner M, et al. Long term behavioural outcome after neonatal arterial switch operation for transposition of the great arteries. Arch Dis Child. 2002; 87:506 –10.
  29. Simko LC, McGinnis KA. Quality of life experienced by adults with con- genital heart disease. AACN Clin Issues. 2003; 14:42–53.
  30. Moons P, Van Deyk K, Marquet K, et al. Individual quality of life in adults with congenital heart disease: a paradigm shift. Eur Heart J. 2005; 26:298 –307.
  31. Van den Bosch AE, Roos-Hesselink JW, Van Domburg R, Bogers AJ, Simoons ML, Meijboom FJ. Long-term outcome and quality of life in adult patients after the Fontan operation. Am J Cardiol. 2004; 93: 1141–5.
  32. Horner T, Liberthson R, Jellinek MS. Psychosocial profile of adults with complex congenital heart disease. Mayo Clin Proc. 2000; 75:31– 6.
  33. Oates RK, Simpson JM, Cartmill TB, Turnbull JA. Intellectual function and age of repair in cyanotic congenital heart disease. Arch Dis Child. 1995; 72:298 –301.
  34. Niwa K, Tateno S, Tatebe S, et al. Social concern and independence in adults with congenital heart disease. J Cardiol. 2002; 39:259–66.
  35. Lane DA, Lip GY, Millane TA. Quality of life in adults with congenital heart disease. Heart. 2002; 88:71–5.
  36. Nieminen H, Sairanen H, Tikanoja T, et al. Long-term results of pediatric cardiac surgery in Finland: education, employment, marital status, and parenthood. Pediatrics. 2003; 112:1345–50.
  37. Moons P, De Blesser L, Budts W, et al. Health status, functional abilities, and quality of life after the Mustard or Senning operation. Ann Thorac Surg. 2004; 77:1359–65.
  38. Utens EM, Verhulst FC, Erdman RA, et al. Psychosocial functioning of young adults after surgical correction for congenital heart disease in hild- hood: a follow-up study. J Psychosom Res. 1994; 38:745–58.
  39. Moons P, Van Deyk K, Marquet K, De Blesser L, Budts W, De Geest S. Sexual functioning and congenital heart disease: Something to worry about? Int J Cardiol. 2007; 121:30 –5.
  40. Crossland DS, Jackson SP, Lyall R, et al. Life insurance and mortgage application in adults with congenital heart disease. Eur J Cardiothorac Surg. 2004; 25:931– 4.
  41. Bromberg JI, Beasley PJ, D’Angelo EJ, Landzberg M, DeMaso DR. Depression and anxiety in adults with congenital heart disease: a pilot study. Heart Lung. 2003; 32:105–10.
  42. Mental Health: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services; 1999.
  43. Foster E, Graham TP Jr, Driscoll DJ, et al. Task force 2: special health care needs of adults with congenital heart disease. J Am Coll Cardiol. 2001; 37:1176–83.
  44. Higgins SS, Tong E. Transitioning adolescents with congenital heart dis- ease into adult health care. Prog Cardiovasc Nurs. 2003; 18:93– 8.
  45. Canobbio MM, Higgins SS. Transitional care issues for the adolescent with congenital heart disease. Nurs Clin North Am. 2004; 39:xiii–xiv.
  46. Canobbio MM. Health care issues facing adolescents with congenital heart disease. J Pediatr Nurs. 2001;16:363–70.
  47. van Rijen EH, Utens EM, Roos-Hesselink JW, et al. Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J. 2004;25:1605–13.
  48. Swan L, Hillis WS. Exercise prescription in adults with congenital heart disease: a long way to go. Heart. 2000;83:685–7.
  49. Graham TP Jr, Driscoll DJ, Gersony WM, Newburger JW, Rocchini A, Towbin JA. Task Force 2: congenital heart disease. J Am Coll Cardiol. 2005;45:1326 –33.
  50. 35th Bethesda Conference. Cardiology’s Workforce Crisis: a pragmatic approach. Bethesda, Maryland, 17–18 October 2003. J Am Coll Cardiol. 2004;44:216 –75.
  51. Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five- to fifteen-year follow-up after Fontan operation. Circulation. 1992; 85:469 – 96.
  52. Fredriksen PM, Therrien J, Veldtman G, et al. Lung function and aerobic capacity in adult patients following modified Fontan procedure. Heart. 2001;85:295–9.
  53. Fredriksen PM, Chen A, Veldtman G, Hechter S, Therrien J, Webb G. Exercise capacity in adult patients with congenitally corrected transposi- tion of the great arteries. Heart. 2001;85:191–5.
  54. Fredriksen PM, Veldtman G, Hechter S, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87:310–4.
  55. Fredriksen PM, Therrien J, Veldtman G, et al. Aerobic capacity in adults with tetralogy of Fallot. Cardiol Young. 2002;12:554 –9.
  56. Harrison DA, Liu P, Walters JE, et al. Cardiopulmonary function in adult patients late after Fontan repair. J Am Coll Cardiol. 1995;26: 1016–21.
  57. Hechter SJ, Webb G, Fredriksen PM, et al. Cardiopulmonary exercise per- formance in adult survivors of the Mustard procedure. Cardiol Young. 2001;11:407–14.
  58. Iserin L, Chua TP, Chambers J, Coats AJ, Somerville J. Dyspnoea and exercise intolerance during cardiopulmonary exercise testing in patients with univentricular heart. The effects of chronic hypoxaemia and Fontan procedure. Eur Heart J. 1997;18:1350–6.
  59. Thaulow E, Fredriksen PM. Exercise and training. In: Gatzoulis MA, Webb GD, Daubeney PE, editors. Diagnosis and Management of Adult Congenital Heart Disease. Churchill Livingstone, 2003:145–9.
  60. Therrien J, Fredriksen P, Walker M, Granton J, Reid GJ, Webb G. A pilot study of exercise training in adult patients with repaired tetralogy of Fallot. Can J Cardiol. 2003;19:685–9.
  61. Fredriksen PM, Kahrs N, Blaasvaer S, et al. Effect of physical training in children and adolescents with congenital heart disease. Cardiol Young. 2000;10:107–14.
  62. Lawrence, J, Schweinhart, Kilbourn, and Rand. Lifetime effects (Monographs of the High/Scope Educational Research Foundation). Ypsilanti, Mich: High/Scope Press; 2005:14.
  63. Hart EM, Garson A Jr. Psychosocial concerns of adults with congenital heart disease. Employability and insurability. Cardiol Clin. 1993;11: 711–5.
  64. Celermajer DS, Deanfield JE. Employment and insurance for young adults with congenital heart disease. Br Heart J. 1993;69:539–43.
  65. McGrath KA, Truesdell SC. Employability and career counseling for ado- lescents and adults with congenital heart disease. Nurs Clin North Am. 1994;29:319 –30.
  66. US Department of Labor. Family and medical leave act. Available at http://www. dol. gov/esa/whd/fmla. Accessed July 19, 2008.
  67. Cumming G. Insurability of adults with congenital heart disease. In: Gatzoulis M, Webb GD, Daubeney PE, editors. Diagnosis and Management of Adult Congenital Heart Disease. Churchill Livingstone, 2003:151– 60.
  68. Mahoney LT, Skorton DJ. Insurability and employability. J Am Coll Cardiol. 1991;18:334–6.
  69. Beauchesne LM, Warnes CA, Connolly HM, et al. Prevalence and clinical manifestations of 22q11. 2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. 2005;45:595– 8.
  70. Momma K, Takao A, Matsuoka R, et al. Tetralogy of Fallot associated with chromosome 22q11. 2 deletion in adolescents and young adults. Genet Med. 2001;3:56–60.
  71. Sparkes RS, Perloff JK. Genetics, epidemiology, counseling, and preven- tion. In: Perloff JK, Child JS, editors. Congenital Heart Disease in Adults. Philadelphia: W. B. Saunders, 1998:165– 88.
  72. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocardi- tis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736 –54.
  73. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318 –30.
  74. Child JS, Perloff JK, Kubak B. Infective endocarditis: risks and prophy- laxis. In: Perloff JK, Child JS, editors. Congenital Heart Disease in Adults. Philadelphia: W. B. Saunders, 1998:129–43.
  75. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998;98: 2936–48.
  76. Bayer AS, Ward JI, Ginzton LE, Shapiro SM. Evaluation of new clinical cri- teria for the diagnosis of infective endocarditis. Am J Med. 1994;96: 211–9.
  77. Fowler VG, Durack DT. Infective endocarditis. Curr Opin Cardiol. 1994;9:389–400.
  78. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diag- nosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J. 2004;25:267–76.
  79. Dodo H, Child JS. Infective endocarditis in congenital heart disease. Cardiol Clin. 1996;14:383–92.
  80. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocardi- tis. Recommendations by the American Heart Association. Circulation. 1997;96:358 – 66.
  81. Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endo- carditis in childhood. Circulation. 2002;105:2115–26.
  82. Deanfield J, Thaulow E, Warnes C, et al. Management of grown up con- genital heart disease. Eur Heart J. 2003;24:1035– 84.
  83. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in The Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med. 1992;152:1869 –73.
  84. van der Meer JT, Thompson J, Valkenburg HA, Michel MF. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med. 1992;152:1863– 8.
  85. Li W, Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J. 1998;19:166 –73.
  86. McKinsey DS, Ratts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med. 1987; 82:681– 8.
  87. Johnson DH, Rosenthal A, Nadas AS. A forty-year review of bacterial endocarditis in infancy and childhood. Circulation. 1975;51:581– 8.
  88. Franco-Paredes C, Workowski K, Harris M. Infective endocarditis endar- teritis complicating coarctation of the aorta. Am J Med. 2002;112: 590–2.
  89. Lamas CC, Eykyn SJ. Bicuspid aortic valve–a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis. 2000;30:336–41.
  90. Brown AK, Anderson V, Gillgren L. Pulmonary valve endocarditis. Am J Cardiol. 1984;54:1170.
  91. Caldwell RL, Hurwitz RA, Girod DA. Subacute bacterial endocarditis in children. Current status. Am J Dis Child. 1971;122:312–5.
  92. Dodo H, Perloff JK, Child JS, Miner PD, Pegues DA. Are high-velocity tri- cuspid and pulmonary regurgitation endocarditis risk substrates? Am Heart J. 1998;136:109 –14.
  93. Kaplan EL, Rich H, Gersony W, Manning J. A collaborative study of infec- tive endocarditis in the 1970s. Emphasis on infections in patients who have undergone cardiovascular surgery. Circulation. 1979;59: 327–35.
  94. Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA. 1998;279: 599–603.
  95. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart. 2002; 88:61– 6.
  96. Prendergast BD. Diagnosis of infective endocarditis. BMJ. 2002;325: 845–6.
  97. Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg. 2002;74:650 –9
  98. Spirito P, Rapezzi C, Bellone P, et al. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation. 1999;99:2132–7.
  99. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococ- ci, and HACEK microorganisms. American Heart Association. JAMA. 1995;274:1706 –13.
  100. Yankah AC, Klose H, Petzina R, Musci M, Siniawski H, Hetzer R. Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience. Eur J Cardiothorac Surg. 2002;21: 260–7.
  101. Gersony WM, Hayes CJ, Driscoll DJ, et al. Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation. 1993;87:I121–I126.
  102. Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122:847–53.
  103. Li W, Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J. 1998;19:166 –73.
  104. Hayes CJ, Gersony WM, Driscoll DJ, et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation. 1993;87(suppl 2):I28 –37.
  105. Niwa K, Nakazawa M, Tateno S, Yoshinaga M, Terai M. Infective endo- carditis in congenital heart disease: Japanese national collaboration study. Heart. 2005;91:795– 800.
  106. DiFilippo S, Delahaye F, Semiond B, et al. Current patterns of infective endocarditis in congenital heart disease. Heart. 2006;92:1490 –5.
  107. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200 –9.
  108. Child JS. Echo-Doppler and color-flow imaging in congenital heart dis- ease. Cardiol Clin. 1990;8:289 –313.
  109. Krivokapich J, Child JS. Role of transthoracic and transesophageal echocardiography in diagnosis and management of infective endocarditis. Cardiol Clin. 1996;14:363– 82.
  110. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: sum- mary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108:1146–62.
  111. Child JS. Transthoracic and transesophageal echocardiographic imaging: anatom- ic and hemodynamic assessment. In: Perloff JK, Child JS, editors. Congenital Heart Disease in Adults. Philadelphia, Pa, W. B. Saunders, 1998:91–128.
  112. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists, endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1– e148.
  113. Blaustein AS, Lee JR. Indications for and timing of surgical intervention in infective endocarditis. Cardiol Clin. 1996;14:393– 404.
  114. Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109: 1745–9.
  115. Chan KL. Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ. 2002;167:19 –24.
  116. Awadallah SM, Kavey RE, Byrum CJ, Smith FC, Kveselis DA, Blackman MS. The changing pattern of infective endocarditis in childhood. Am J Cardiol. 1991;68:90–4.
  117. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89:2673– 6.
  118. Delahaye F, Rial MO, de Gevigney G, Ecochard R, Delaye J. A critical appraisal of the quality of the management of infective endocarditis. J Am Coll Cardiol. 1999;33:788 –93.
  119. Kubak BM, Nimmagadda AP, Holt CD. Advances in medical and antibiot- ic management of infective endocarditis. Cardiol Clin. 1996;14: 405–36.
  120. Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol. 2003;42:775– 80.
  121. Drinkwater DC Jr, Laks H, Child JS. Issues in surgical treatment of endo- carditis including intraoperative and postoperative management. Cardiol Clin. 1996;14:451– 64.
  122. Oliver R, Roberts GJ, Hooper L. Penicillins for prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev. 2004;(2): CD003813.
  123. Gould FK, Elliott TS, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2006;57: 1035–42.
  124. Ashrafian H, Bogle RG. Antimicrobial prophylaxis for endocarditis: emo- tion or science? Heart. 2007;93:5– 6.
  125. Cetta F, Warnes CA. Adults with congenital heart disease: patient knowl- edge of endocarditis prophylaxis. Mayo Clin Proc. 1995;70:50–4.
  126. Ammash NM, Connolly HM, Abel MD, Warnes CA. Noncardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol. 1999;33:222–7.
  127. Territo MC, Rosove MH. Cyanotic congenital heart disease: hematologic management. J Am Coll Cardiol. 1991;18:320 –2.
  128. Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100:1307–9.
  129. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose- dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999;33:1637– 41.
  130. Sareli P, England MJ, Berk MR, et al. Maternal and fetal sequelae of anti- coagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol. 1989;63:1462–5.
  131. van Driel D, Wesseling J, Sauer PJ, van Der Veer E, Touwen BC, Smrkovsky M. In utero exposure to coumarins and cognition at 8 to 14 years old. Pediatrics. 2001;107:123–9.
  132. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of preg- nancy outcomes in women with heart disease. Circulation. 2001; 104:515–21.
  133. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac out- comes are more common in pregnant women with cardiac disease. Circulation. 2002;105:2179–84.
  134. Siu SC, Colman JM. Heart disease and pregnancy. Heart. 2001;85: 710–5.
  135. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital mal- formations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443–51.
  136. Schaefer C, Hannemann D, Meister R, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost. 2006;95:949 –57.
  137. Famuyide AO, Hopkins MR, El-Nashar SA, et al. Hysteroscopic steriliza- tion in women with severe cardiac disease: experience at a tertiary center. Mayo Clin Proc. 2008;83:431– 8.
  138. Epstein AE, Di Marco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnomalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pace- makers and antiarrhythmia devices). J Am Coll Cardiol. 2008;51:e1– 62.
  139. Fishberger SB, Wernovsky G, Gentles TL, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997;113:80–6.
  140. Walsh EP, Rockenmacher S, Keane JF, Hougen TJ, Lock JE, Castaneda AR. Late results in patients with tetralogy of Fallot repaired during infan- cy. Circulation. 1988;77:1062–7.
  141. Reich JD, Auld D, Hulse E, Sullivan K, Campbell R. The Pediatric Radiofrequency Ablation Registry’s experience with Ebstein’s anomaly. Pediatric Electrophysiology Society. J Cardiovasc Electrophysiol. 1998; 9:1370 –7.
  142. Khositseth A, Danielson GK, Dearani JA, Munger TM, Porter CJ. upraven- tricular tachyarrhythmias in Ebstein anomaly: management and out- come. J Thorac Cardiovasc Surg. 2004;128:826 –33.
  143. Chetaille P, Walsh EP, Triedman JK. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004;1:168 –73.
  144. Flinn CJ, Wolff GS, Dick M, et al. Cardiac rhythm after the Mustard oper- ation for complete transposition of the great arteries. N Engl J Med. 1984;310:1635– 8.
  145. Ghai A, Harris L, Harrison DA, Webb GD, Siu SC. Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation. J Am Coll Cardiol. 2001;37:585–92.
  146. Nakagawa H, Shah N, Matsudaira K, et al. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow “focal” ablation. Circulation. 2001;103:699 –709.
  147. Triedman JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30: 1032–8.
  148. Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of ‘incisional’ reentrant atrial tachycardia complicating surgery for con- genital heart disease. Use of entrainment to define a critical isthmus of conduction. Circulation. 1996;93:502–12.
  149. Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985;6: 871–8.
  150. Rhodes LA, Walsh EP, Gamble WJ, Triedman JK, Saul JP. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995;18:1005–16.
  151. Li W, Somerville J. Atrial flutter in grown-up congenital heart (GUCH) patients. Clinical characteristics of affected population. Int J Cardiol. 2000;75:129 –37.
  152. Anand N, McCrindle BW, Chiu CC, et al. Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study. Eur Heart J. 2006;27:2069 –73.
  153. Triedman JK. Atrial reentrant tachycardias. In: Walsh EP, Saul JP, Triedman JK, editors. Cardiac Arrhythmias in Children and Young Adults With Congenital Heart Disease. Philadelphia: Lippincott Williams & Wilkins; 2001:137– 60.
  154. Deleted in proof.
  155. Stephenson EA, Casavant D, Tuzi J, et al. Efficacy of atrial antitachycar- dia pacing using the Medtronic AT500 pacemaker in patients with con- genital heart disease. Am J Cardiol. 2003;92:871– 6.
  156. Triedman JK, Alexander ME, Berul CI, Bevilacqua LM, Walsh EP. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001;103:2060 –5.
  157. Delacretaz E, Ganz LI, Soejima K, et al. Multi atrial macro-re-entry cir- cuits in adults with repaired congenital heart disease: entrainment map- ping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001;37:1665–76.
  158. Jais P, Shah DC, Haissaguerre M, et al. Prospective randomized compari- son of irrigated-tip versus conventional-tip catheters for ablation of com- mon flutter. Circulation. 2000;101:772– 6.
  159. Triedman JK, Alexander ME, Love BA, et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart dis- ease. J Am Coll Cardiol. 2002;39:1827–35.
  160. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001;122: 863–71.
  161. Kirsh JA, Walsh EP, Triedman JK. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002;90:338–40.
  162. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30:1374–83.
  163. Murphy LS. The Delaware Limited Liability Company: a new form of busi- ness. Del Med J. 1993;65:329 –31.
  164. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhyth- mias in adults after repair of tetralogy of Fallot. Correlations with clini- cal, exercise, and echocardiographic findings. Circulation. 1995;91: 2214–9.
  165. Chandar JS, Wolff GS, Garson A Jr, et al. Ventricular arrhythmias in post- operative tetralogy of Fallot. Am J Cardiol. 1990;65:655– 61.
  166. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975 – 81.
  167. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventric- ular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–7.
  168. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK. Value of pro- grammed ventricular stimulation in patients with congenital heart dis- ease. J Cardiovasc Electrophysiol. 1999;10:1033– 44.
  169. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ven- tricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004;109:1994 –2000.
  170. Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489 –94.
  171. Goldner BG, Cooper R, Blau W, Cohen TJ. Radiofrequency catheter ablation as a primary therapy for treatment of ventricular tachycardia in a patient after repair of tetralogy of Fallot. Pacing Clin Electrophysiol. 1994;17:1441– 6.
  172. Burton ME, Leon AR. Radiofrequency catheter ablation of right ventricu- lar outflow tract tachycardia late after complete repair of tetralogy of Fallot using the pace mapping technique. Pacing Clin Electrophysiol. 1993;16:2319 –25.
  173. Gonska BD, Cao K, Raab J, Eigster G, Kreuzer H. Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects. Circulation. 1996;94:1902– 8.
  174. Morwood JG, Triedman JK, Berul CI, et al. Radiofrequency catheter abla- tion of ventricular tachycardia in children and young adults with congen- ital heart disease. Heart Rhythm. 2004;1:301– 8.
  175. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004;15:72– 6.
  176. Manning PB, Mayer JE Jr, Wernovsky G, Fishberger SB, Walsh EP. Staged operation to Fontan increases the incidence of sinoatrial node dysfunc- tion. J Thorac Cardiovasc Surg. 1996;111:833–9.
  177. Wong T, Davlouros PA, Li W, Millington-Sanders C, Francis DP, Gatzoulis MA. Mechano-electrical interaction late after Fontan operation: relation between P-wave duration and dispersion, right atrial size, and atrial arrhythmias. Circulation. 2004;109:2319 –25.
  178. Anderson RH, Ho SY. The disposition of the conduction tissues in congen- itally malformed hearts with reference to their embryological develop- ment. J Perinat Med. 1991;(suppl 1):201– 6.
  179. Weindling SN, Saul JP, Gamble WJ, Mayer JE, Wessel D, Walsh EP. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998;82:525–7.
  180. Anderson RH, Becker AE, Arnold R, Wilkinson JL. The conducting tissues in congenitally corrected transposition. Circulation. 1974;50: 911–23.
  181. VanPraagh R, Papagiannis J, Grunenfelder J, Bartram U, Martanovic P. Pathologic anatomy of corrected transposition of the great arteries: med- ical and surgical implications. Am Heart J. 1998;135:772– 85.
  182. Thiene G, Wenink AC, Frescura C, et al. Surgical anatomy and pathology of the conduction tissues in atrioventricular defects. J Thorac Cardiovasc Surg. 1981;82:928 –37.
  183. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congen- ital heart disease: hematologic management. Ann Inter Med. 1988;109:406 –13.
  184. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol. 1996;28:768 –72.
  185. Flanagan MF, Hourihan M, Keane JF. Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol. 1991;68: 403–6.
  186. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin. 1993;11:689 –99.
  187. Graham TP Jr, Bricker JT, James FW, Strong WB. 26th Bethesda confer- ence: recommendations for determining eligibility for competition in ath- letes with cardiovascular abnormalities. Task Force 1: congenital heart disease. Med Sci Sports Exerc. 1994;26:S246 –S253.
  188. Sietsema KE. Cyanotic congenital heart disease: dynamics of oxygen uptake and ventilation during exercise. J Am Coll Cardiol. 1991;18: 322–3.
  189. Sietsema KE, Cooper DM, Perloff JK, et al. Control of ventilation during exercise in patients with central venous-to-systemic arterial shunts. J Appl Physiol. 1988;64:234–42.
  190. Sietsema KE, Cooper DM, Perloff JK, et al. Dynamics of oxygen uptake during exercise in adults with cyanotic congenital heart disease. Circulation. 1986;73:1137– 44.
  191. Warnes CA, Somerville J. Tricuspid atresia in adolescents and adults: cur- rent state and late complications. Br Heart J. 1986;56:535– 43.
  192. Eidem BW, O’Leary PW, Tei C, Seward JB. Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease. Am J Cardiol. 2000;86:654–8.
  193. Perlowski A, Child JS, Ross R, Miner PD. Brain natriuretic peptide may be predictive of myocardial performance in congeital heart disease patients. J Am Coll Cardiol. 2004;43:391A.
  194. Salehian O, Schwerzmann M, Merchant N, Webb GD, Siu SC, Therrien J. Assessment of systemic right ventricular function in patients with transposi- tion of the great arteries using the myocardial performance index: comparison with cardiac magnetic resonance imaging. Circulation. 2004;110:3229 –33.
  195. Hornung TS, Bernard EJ, Celermajer DS, et al. Right ventricular dysfunc- tion in congenitally corrected transposition of the great arteries. Am J Cardiol. 1999;84:1116 –9, A10.
  196. Lakatta EG. Deficient neuroendocrine regulation of the cardiovascular sys- tem with advancing age in healthy humans. Circulation. 1993;87: 631–6.
  197. Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ven- tricular interdependence in patients with atrial septal defects. Am J Cardiol. 2004;93:1374 –7, A6.
  198. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type natriuretic pep- tide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol. 2004;43:416 –22.
  199. Torrent-Guasp F, Ballester M, Buckberg GD, et al. Spatial orientation of the ventricular muscle band: physiologic contribution and surgical impli- cations. J Thorac Cardiovasc Surg. 2001;122:389 –92.
  200. Buckberg GD, Weisfeldt ML, Ballester M, et al. Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. Circulation. 2004;110:e333– e336.
  201. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and manage- ment of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1– e82.
  202. Pignatelli RH, McMahon CJ, Chung T, Vick GW III. Role of echocardiogra- phy versus MRI for the diagnosis of congenital heart disease. Curr Opin Cardiol. 2003;18:357– 65.
  203. Tulevski II, van der Wall EE, Groenink M, et al. Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol. 2002;89:1077– 81.
  204. Prakash A, Powell AJ, Krishnamurthy R, Geva T. Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol. 2004;93:657– 61.
  205. Fogel MA, Weinberg PM, Fellows KE, Hoffman EA. A study in ventricular- ventricular interaction. Single right ventricles compared with systemic right ventricles in a dual-chamber circulation. Circulation. 1995;92:219 –30.
  206. Fogel MA, Weinberg PM, Gupta KB, et al. Mechanics of the single left ven- tricle: a study in ventricular-ventricular interaction II. Circulation. 1998;98:330–8.
  207. Eidem BW, Tei C, O’Leary PW, Cetta F, Seward JB. Nongeometric quantita- tive assessment of right and left ventricular function: myocardial per- formance index in normal children and patients with Ebstein anomaly. J Am Soc Echocardiogr. 1998;11:849 –56.
  208. Williams RV, Ritter S, Tani LY, Pagoto LT, Minich LL. Quantitative assessment of ventricular function in children with single ventricles using the Doppler myocardial performance index. Am J Cardiol. 2000; 86:1106 –10.
  209. Vanderheyden M, Goethals M, Verstreken S, et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopa- thy. J Am Coll Cardiol. 2004;44:2349 –54.
  210. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation. 2004; 109:2872–7.
  211. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350:655– 63.
  212. Maisel AS. Use of BNP levels in monitoring hospitalized heart failure patients with heart failure. Heart Fail Rev. 2003;8:339–44.
  213. Yan AT, Yan RT, Liu PP. Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials. Ann Intern Med. 2005;142:132– 45.
  214. McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation. 2004;110:3281– 8.
  215. Teerlink JR, Massie BM. Nesiritide and worsening of renal function: the emperor’s new clothes? Circulation. 2005;111:1459–61.
  216. Gring CN, Francis GS. A hard look at angiotensin receptor blockers in heart failure. J Am Coll Cardiol. 2004;44:1841– 6.
  217. Sliwa K, Norton GR, Kone N, et al. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. J Am Coll Cardiol. 2004;44: 1825–30.
  218. Leier CV. Dismantling mandates in the treatment of heart failure. J Am Coll Cardiol. 2004;44:1831–3.
  219. Ringel RE, Peddy SB. Effect of high-dose spironolactone on proteinlosing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol. 2003;91:1031–2, A9.
  220. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chron- ic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106:92–9.
  221. Davos CH, Davlouros PA, Wensel R, et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation. 2003;108(suppl I):II180 –5.
  222. Davos CH, Francis DP, Leenarts MF, et al. Global impairment of cardiac autonomic nervous activity late after the Fontan operation. Circulation. 2002;106 (suppl I):I69 –75.
  223. Daliento L, Rizzoli G, Menti L, et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart. 1999;81: 650–5.
  224. Ohuchi H, Hasegawa S, Yasuda K, Yamada O, Ono Y, Echigo S. Severely impaired cardiac autonomic nervous activity after the Fontan operation. Circulation. 2001;104:1513– 8.
  225. Ohuchi H, Ohashi H, Park J, Hayashi J, Miyazaki A, Echigo S. Abnormal postexercise cardiovascular recovery and its determinants in patients after right ventricular outflow tract reconstruction. Circulation. 2002;106:2819 –26.
  226. Ohuchi H, Takasugi H, Ohashi H, et al. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional sta- tus in Fontan patients. Circulation. 2004;110:2601– 8.
  227. Perloff JK, Warnes CA. Challenges posed by adults with repaired congen- ital heart disease. Circulation. 2001;103:2637– 43.
  228. Thambo JB, Bordachar P, Garrigue S, et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation. 2004;110:3766 –72.
  229. Nahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger JJ. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol. 2004;44:1883– 8.
  230. Janousek J, Tomek V, Chaloupecky VA, et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004;44:1927–31.
  231. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascu- lar resistance and cardiac transplantation. Circulation. 1987;76: V52–V55.
  232. Zales VR, Dunnigan A, Benson DW Jr. Clinical and electrophysiologic fea- tures of fetal and neonatal paroxysmal atrial tachycardia resulting in con- gestive heart failure. Am J Cardiol. 1988;62:225– 8.
  233. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart trans- plantation. J Heart Transplant. 1988;7:331– 6.
  234. Spray TL, Mallory GB, Canter CE, Huddleston CB, Kaiser LR. Pediatric lung transplantation for pulmonary hypertension and congenital heart disease. Ann Thorac Surg. 1992;54:216 –23.
  235. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report–2007. J Heart Lung Transplant. 2007;26: 769–81.
  236. Waltz DA, Boucek MM, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric lung and heart-lung transplantation report–2006. J Heart Lung Transplant. 2006;25:904 –11.
  237. Choong CK, Meyers BF, Battafarano RJ, et al. Lung cancer resection com- bined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg. 2004;127:1323–31.
  238. Fuster V, Brandenburg RO, McGoon DC, Giuliani ER. Clinical approach and management of congenital heart disease in the adolescent and adult. Cardiovasc Clin. 1980;10:161–97.
  239. Rigby M. Atrial septal defect. In: Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingston, 2003.
  240. Schreiber TL, Feigenbaum H, Weyman AE. Effect of atrial septal defect repair on left ventricular geometry and degree of mitral valve prolapse. Circulation. 1980;61:888 –96.
  241. Ballester M, Presbitero P, Foale R, Rickards A, McDonald L. Prolapse of the mitral valve in secundum atrial septal defect: a functional mechanism. Eur Heart J. 1983;4:472– 6.
  242. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J. 1986;112:141–5.
  243. Silka MJ, Rice MJ. Paradoxic embolism due to altered hemodynamic sequencing following transvenous pacing. Pacing Clin Electrophysiol. 1991;14:499 –503.
  244. Ward R, Jones D, Haponik EF. Paradoxical embolism. An underrecognized problem. Chest. 1995;108:549 –58.
  245. Konstantinides S, Geibel A, Olschewski M, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med. 1995;333:469 –73.
  246. Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation. 1968;37:805–15.
  247. Bizarro RO, Callahan JA, Feldt RH, Kurland LT, Gordon H, Brandenburg RO. Familial atrial septal defect with prolonged atrioventricular conduc- tion. A syndrome showing the autosomal dominant pattern of inheri- tance. Circulation. 1970;41:677– 83.
  248. Kronzon I, Tunick PA, Freedberg RS, Trehan N, Rosenzweig BP, Schwinger ME. Transesophageal echocardiography is superior to transthoracic echocardiography in the diagnosis of sinus venosus atrial septal defect. J Am Coll Cardiol. 1991;17:537– 42.
  249. Mehta RH, Helmcke F, Nanda NC, Pinheiro L, Samdarshi TE, Shah VK. Uses and limitations of transthoracic echocardiography in the assess- ment of atrial septal defect in the adult. Am J Cardiol. 1991;67: 288–94.
  250. Mehta RH, Helmcke F, Nanda NC, Hsiung M, Pacifico AD, Hsu TL. Transesophageal Doppler color flow mapping assessment of atrial septal defect. J Am Coll Cardiol. 1990;16:1010–6.
  251. Pascoe RD, Oh JK, Warnes CA, Danielson GK, Tajik AJ, Seward JB. Diagnosis of sinus venosus atrial septal defect with transesophageal echocardiography. Circulation. 1996;94:1049 –55.
  252. Fraker TD Jr, Harris PJ, Behar VS, Kisslo JA. Detection and exclusion of interatrial shunts by two-dimensional echocardiography and peripheral venous injection. Circulation. 1979;59:379–84.
  253. Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracar- diac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation. 1995;91:2955– 60.
  254. Holmvang G, Palacios IF, Vlahakes GJ, et al. Imaging and sizing of atrial septal defects by magnetic resonance. Circulation. 1995;92: 3473–80.
  255. Taylor AM, Stables RH, Poole-Wilson PA, Pennell DJ. Definitive clinical assessment of atrial septal defect by magnetic resonance imaging. J Cardiovasc Magn Reson. 1999;1:43–7.
  256. Boxt LM. Magnetic resonance and computed tomographic evaluation of congenital heart disease. J Magn Reson Imaging. 2004;19:827– 47.
  257. Freed MD, Nadas AS, Norwood WI, Castaneda AR. Is routine preoperative cardiac catheterization necessary before repair of secundum and sinus venosus atrial septal defects? J Am Coll Cardiol. 1984;4:333– 6.
  258. Shub C, Tajik AJ, Seward JB, Hagler DJ, Danielson GK. Surgical repair of uncomplicated atrial septal defect without “routine” preoperative cardiac catheterization. J Am Coll Cardiol. 1985;6:49 –54.
  259. Prystowsky EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996;93:1262–77.
  260. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consec- utive patients. Heart. 2003;89:199 –204.
  261. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836–44.
  262. Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart. 1999;82:559–62.
  263. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650 –7.
  264. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19: 1845–55.
  265. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnan- cyrelated complications in women with heart disease. Circulation. 1997;96: 2789–94.
  266. Benson DW, Sharkey A, Fatkin D, et al. Reduced penetrance, variable expressivity, and genetic heterogeneity of familial atrial septal defects. Circulation. 1998;97:2043– 8.
  267. Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998; 81:108 –11.
  268. Pease WE, Nordenberg A, Ladda RL. Familial atrial septal defect with pro- longed atrioventricular conduction. Circulation. 1976;53:759–62.
  269. Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol. 1994;23:1459–67.
  270. Basson CT, Bachinsky DR, Lin RC, et al. Mutations in human TBX5 [cor- rected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997;15:30 –5.
  271. Basson CT, Solomon SD, Weissman B, et al. Genetic heterogeneity of heart-hand syndromes. Circulation. 1995;91:1326 –9.
  272. Holt M, Oram S. Familial heart disease with skeletal malformations. Br Heart J. 1960;22:236–42.
  273. Helber U, Baumann R, Seboldt H, Reinhard U, Hoffmeister HM. Atrial sep- tal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol. 1997;29: 1345–50.
  274. Graham TP Jr, Bricker JT, James FW, Strong WB. 26th Bethesda confer- ence: recommendations for determining eligibility for competition in ath- letes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol. 1994;24:867–73.
  275. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890 –900.
  276. Du ZD, Roguin N, Wu XJ. Spontaneous closure of muscular ventricular septal defect identified by echocardiography in neonates. Cardiol Young. 1998;8:500 –5.
  277. Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation. 1993;87:I38-I51.
  278. Graham TP Jr, Gutgesell HP. Ventricular septal defects. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, edi- tors. Moss and Adams Heart Disease in Infants, Children and Adolescents. Baltimore: Williams & Wilkins; 1989:724–46.
  279. Prosad S. Ventricular septal defects. In: Gatzoulis MA, Webb GD, Daubeney PE, editors. Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingstone; 2003:171– 8.
  280. Jacobs JP, Burke RP, Quintessenza JA, Mavroudis C. Congenital heart surgery nomenclature and database project: ventricular septal defect. Ann Thorac Surg. 2000;69:S25–S35.
  281. Neumayer U, Stone S, Somerville J. Small ventricular septal defects in adults. Eur Heart J. 1998;19:1573– 82.
  282. Onat T, Ahunbay G, Batmaz G, Celebi A. The natural course of isolated ven- tricular septal defect during adolescence. Pediatr Cardiol. 1998;19: 230–4.
  283. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular sep- tal defect occluder: immediate and mid-term results of a US registry. J Am Coll Cardiol. 2004;43:1257– 63.
  284. John S, Muralidharan S, Jairaj PS, et al. The adult ductus: review of sur- gical experience with 131 patients. J Thorac Cardiovasc Surg. 1981; 82:314 –9.
  285. Fisher RG, Moodie DS, Sterba R, Gill CC. Patent ductus arteriosus in adults–long-term follow-up: nonsurgical versus surgical treatment. J Am Coll Cardiol. 1986;8:280–4.
  286. Ng AS, Vlietstra RE, Danielson GK, Smith HC, Puga FJ. Patent ductus arteriosus in patients more than 50 years old. Int J Cardiol. 1986;11: 277–85.
  287. Ananthasubramaniam K. Patent ductus arteriosus in elderly patients: clinical and echocardiographic features-a case-based review. J Am Soc Echocardiogr. 2001;14:321– 4.
  288. Arora R, Kalra GS, Nigam M, Khalillulah M. Transcatheter occlusion of patent ductus arteriosus by Rashkind umbrella device: follow-up results. Am Heart J. 1994;128:539–41.
  289. Arora R, Singh S, Dalra GS. Patent ductus arteriosus: catheter closure in the adult patient. J Interv Cardiol. 2001;14:255–9.
  290. Bilkis AA, Alwi M, Hasri S, et al. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol. 2001;37:258–61.
  291. Bonhoeffer P, Borghi A, Onorato E, Carminati M. Transfemoral closure of patent ductus arteriosus in adult patients. Int J Cardiol. 1993;39: 181–6.
  292. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv. 2000;51:50–4.
  293. Harrison DA, Benson LN, Lazzam C, Walters JE, Siu S, McLaughlin PR. Percutaneous catheter closure of the persistently patent ductus arterio- sus in the adult. Am J Cardiol. 1996;77:1094 –7.
  294. Hijazi ZM, Geggel RL. Results of anterograde transcatheter closure of patent ductus arteriosus using single or multiple Gianturco coils. Am J Cardiol. 1994;74:925–9.
  295. Hijazi ZM, Lloyd TR, Beekman RH III, Geggel RL. Transcatheter closure with single or multiple Gianturco coils of patent ductus arteriosus in infants weighing _ or _ 8 kg: retrograde versus antegrade approach. Am Heart J. 1996;132:827–35.
  296. Hong TE, Hellenbrand WE, Hijazi ZM. Transcatheter closure of patent ductus arteriosus in adults using the Amplatzer duct occluder: initial results and follow-up. Indian Heart J. 2002;54:384 –9.
  297. Hosking MC, Benson LN, Musewe N, Dyck JD, Freedom RM. Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow- up and prevalence of residual shunting. Circulation. 1991;84:2313–7.
  298. Ing FF, Mullins CE, Rose M, Shapir Y, Bierman FZ. Transcatheter closure of the patient ductus arteriosus in adults using the Gianturco coil. Clin Cardiol. 1996;19:875–9.
  299. Krichenko A, Benson LN, Burrows P, Moes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent duc- tus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989;63:877– 80.
  300. Lee CH, Leung YL, Chow WH. Transcatheter closure of the patent ductus arteriosus using an Amplatzer duct occluder in adults. Jpn Heart J. 2001;42:533–7.
  301. Lee CH, Leung YL, Kwong NP, Kwok OH, Yip AS, Chow WH. Transcatheter closure of patent ductus arteriosus in Chinese adults: immediate and long-term results. J Invasive Cardiol. 2003;15:26 –30.
  302. Lloyd TR, Fedderly R, Mendelsohn AM, Sandhu SK, Beekman RH III. Transcatheter occlusion of patent ductus arteriosus with Gianturco coils. Circulation. 1993;88:1412–20.
  303. Masura J, Walsh KP, Thanopoulous B, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol. 1998;31:878–82.
  304. Moore JW, George L, Kirkpatrick SE, et al. Percutaneous closure of the small patent ductus arteriosus using occluding spring coils. J Am Coll Cardiol. 1994;23:759–65.
  305. Podnar T, Gavora P, Masura J. Percutaneous closure of patent ductus arteriosus: complementary use of detachable Cook patent ductus arterio- sus coils and Amplatzer duct occluders. Eur J Pediatr. 2000;159: 293–6.
  306. Rao PS, Sideris EB. Transcatheter occlusion of patent ductus arteriosus: state of the art. J Invasive Cardiol. 1996;8:278–88.
  307. Rao PS, Kim SH, Rey C, Onorato E, Sideris EB. Results of transvenous but- toned device occlusion of patent ductus arteriosus in adults. International Buttoned Device Trial Group. Am J Cardiol. 1998;82:827–9, A10.
  308. Rashkind WJ, Mullins CE, Hellenbrand WE, Tait MA. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System. Circulation. 1987;75:583–92.
  309. Schenck MH, O’Laughlin MP, Rokey R, Ludomirsky A, Mullins CE. Transcatheter occlusion of patent ductus arteriosus in adults. Am J Cardiol. 1993;72:591–5.
  310. Shamsham F, Kwan T, Safi AM, Clark LT. Successful transcatheter closure of a patent ductus arteriosus: using two Gianturco coils in a 41-year-old woman. A case report. Angiology. 1999;50:519 –22.
  311. Sievert H, Ensslen R, Fach A, et al. Transcatheter closure of patent ductus arteriosus with the Rashkind occluder. Acute results and angiographic follow-up in adults. Eur Heart J. 1997;18:1014–8.
  312. Verin VE, Saveliev SV, Kolody SM, Prokubovski VI. Results of tran- scatheter closure of the patent ductus arteriosus with the Botallooccluder. J Am Coll Cardiol. 1993;22:1509 –14.
  313. Wang JK, Liau CS, Huang JJ, et al. Transcatheter closure of patent duc- tus arteriosus using Gianturco coils in adolescents and adults. Catheter Cardiovasc Interv. 2002;55:513– 8.
  314. Yamaguchi T, Fukuoka H, Yamamoto K, Katsuta S, Ohta M. Transfemoral closure of patent ductus arteriosus: an alternative to surgery in older patients. Cardiovasc Intervent Radiol. 1990;13:291–3.
  315. Zanchetta M, Dimopoulos K, Rigatelli G, et al. Patent ductus arteriosus closure using the new Amplatzer Duct Occluder. Preliminary results and review of the literature. Minerva Cardioangiol. 2001;49:369 –76.
  316. Ali Khan MA, Mullins CE, Nihill MR, et al. Percutaneous catheter closure of the ductus arteriosus in children and young adults. Am J Cardiol. 1989;64:218 –21.
  317. Celermajer DS, Sholler GF, Hughes CF, Baird DK. Persistent ductus arte- riosus in adults. A review of surgical experience with 25 patients. Med J Aust. 1991;155:233– 6.
  318. Aboulhosn J, Child JS. Left ventricular outflow obstruction: subaortic stenosis, bicuspid aortic valve, supravalvar aortic stenosis, and coarcta- tion of the aorta. Circulation. 2006;114:2412–22.
  319. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493–501.
  320. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation. 2002;106:900–4.
  321. Niwa K, Perloff JK, Bhuta SM, et al. Structural abnormalities of great arte- rial walls in congenital heart disease: light and electron microscopic analyses. Circulation. 2001;103:393– 400.
  322. de Sa M, Moshkovitz Y, Butany J, David TE. Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aor- tic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg. 1999;118:588 –94.
  323. Bauer M, Pasic M, Meyer R, et al. Morphometric analysis of aortic media in patients with bicuspid and tricuspid aortic valve. Ann Thorac Surg. 2002;74:58–62.
  324. Hutchins GM, Nazarian IH, Bulkley BH. Association of left dominant coro- nary arterial system with congenital bicuspid aortic valve. Am J Cardiol. 1978;42:57–9.
  325. Robicsek F, Thubrikar MJ, Cook JW, Fowler B. The congenitally bicuspid aortic valve: how does it function? Why does it fail? Ann Thorac Surg. 2004;77:177– 85.
  326. Beller CJ, Labrosse MR, Thubrikar MJ, Robicsek F. Role of aortic root motion in the pathogenesis of aortic dissection. Circulation. 2004;109: 763–9.
  327. Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S, Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aor- tic valves. Am J Cardiol. 1993;71:322–7.
  328. Chan KL, Ghani M, Woodend K, Burwash IG. Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am J Cardiol. 2001;88:690 –3.
  329. Mautner GC, Mautner SL, Cannon RO III, Hunsberger SA, Roberts WC. Clinical factors useful in predicting aortic valve structure in patients 40 years of age with isolated valvular aortic stenosis. Am J Cardiol. 1993; 72:194–8.
  330. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26:72– 83.
  331. Schievink WI, Mokri B. Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve. Stroke. 1995;26: 1935–40.
  332. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during pro- longed follow-up. Circulation. 2005;111:3290 –5.
  333. Lindsay J Jr. Coarctation of the aorta, bicuspid aortic valve and abnormal ascending aortic wall. Am J Cardiol. 1988;61:182– 4.
  334. Roberts CS, Roberts WC. Dissection of the aorta associated with congeni- tal malformation of the aortic valve. J Am Coll Cardiol. 1991;17: 712–6.
  335. Russo CF, Mazzetti S, Garatti A, et al. Aortic complications after bicuspid aortic valve replacement: long-term results. Ann Thorac Surg. 2002;74:S1773–S1776.
  336. Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19 –22.
  337. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with twodimen- sional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777– 802.
  338. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.
  339. Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005;112:125–34. 340. Aikawa E, Nahrendorf M, Sosnovik D, et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007;115:377– 86.
  340. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554–61.
  341. Rao V, Van Arsdell GS, David TE, Azakie A, Williams WG. Aortic valve repair for adult congenital heart disease: a 22-year experience. Circulation. 2000;102(suppl III):III5–9.
  342. Simon-Kupilik N, Bialy J, Moidl R, et al. Dilatation of the autograft root after the Ross operation. Eur J Cardiothorac Surg. 2002;21:470 –3.
  343. Schmidtke C, Bechtel M, Hueppe M, Sievers HH. Time course of aortic valve function and root dimensions after subcoronary Ross procedure for bicuspid versus tricuspid aortic valve disease. Circulation. 2001; 104(suppl I):I21– 4.
  344. Sievers H, Dahmen G, Graf B, Stierle U, Ziegler A, Schmidtke C. Midterm results of the Ross procedure preserving the patient’s aortic root. Circulation. 2003;108 Suppl 1:II55– 60.
  345. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:245–51.
  346. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular sep- tal defect. Results of 24-hour ECG monitoring. Circulation. 1993; 87:I89 –101.
  347. Silversides CK, Colman JM, Sermer M, Farine D, Siu SC. Early and inter- mediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91:1386 –9.
  348. Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart dis- ease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893–9.
  349. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol. 2003;42:1982–7.
  350. Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005;46:223–30.
  351. Oliver JM, Gonzalez A, Gallego P, Sanchez-Recalde A, Benito F, Mesa JM. Discrete subaortic stenosis in adults: increased prevalence and slow rate of progression of the obstruction and aortic regurgitation. J Am Coll Cardiol. 2001;38:835– 42.
  352. Cilliers AM, Gewillig M. Rheology of discrete subaortic stenosis. Heart. 2002;88:335– 6.
  353. McMahon CJ, Gauvreau K, Edwards JC, Geva T. Risk factors for aortic valve dysfunction in children with discrete subvalvar aortic stenosis. Am J Cardiol. 2004;94:459–64.
  354. Gersony WM. Natural history of discrete subvalvar aortic stenosis: man- agement implications. J Am Coll Cardiol. 2001;38:843–5.
  355. Katz NM, Buckley MJ, Liberthson RR. Discrete membranous subaortic stenosis. Report of 31 patients, review of the literature, and delineation of management. Circulation. 1977;56:1034–8.
  356. Parry AJ, Kovalchin JP, Suda K, et al. Resection of subaortic stenosis: can a more aggressive approach be justified? Eur J Cardiothorac Surg. 1999;15:631– 8.
  357. Brauner R, Laks H, Drinkwater DC Jr, Shvarts O, Eghbali K, Galindo A. Benefits of early surgical repair in fixed subaortic stenosis. J Am Coll Cardiol. 1997;30:1835– 42.
  358. Geva A, McMahon CJ, Gauvreau K, Mohammed L, Del Nido PJ, Geva T. Risk factors for reoperation after repair of discrete subaortic stenosis in children. J Am Coll Cardiol. 2007;50:1498 –504.
  359. Roberts WC. The status of the coronary arteries in fatal ischemic heart disease. Cardiovasc Clin. 1975;7:1–24.
  360. Martin MM, Lemmer JH Jr, Shaffer E, Dick M, Bove EL. Obstruction to left coronary artery blood flow secondary to obliteration of the coronary ostium in supravalvular aortic stenosis. Ann Thorac Surg. 1988; 45:16 –20.
  361. Yilmaz AT, Arslan M, Ozal E, Byngol H, Tatar H, Ozturk OY. Coronary artery aneurysm associated with adult supravalvular aortic stenosis. Ann Thorac Surg. 1996;62:1205–7.
  362. van Son JA, Edwards WD, Danielson GK. Pathology of coronary arteries, myocardium, and great arteries in supravalvular aortic stenosis. Report of five cases with implications for surgical treatment. J Thorac Cardiovasc Surg. 1994;108:21– 8.
  363. Doty DB, Eastham CL, Hiratzka LF, Wright CB, Marcus ML. Determination of coronary reserve in patients with supravalvular aortic stenosis. Circulation. 1982;66:I186-I192.
  364. Thistlethwaite PA, Madani MM, Kriett JM, Milhoan K, Jamieson SW. Surgical management of congenital obstruction of the left main coronary artery with supravalvular aortic stenosis. J Thorac Cardiovasc Surg. 2000;120:1040–6.
  365. Nielsen JC, Powell AJ, Gauvreau K, Marcus EN, Prakash A, Geva T. Magnetic resonance imaging predictors of coarctation severity. Circulation. 2005;111:622– 8.
  366. McCrindle BW, Jones TK, Morrow WR, et al. Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. J Am Coll Cardiol. 1996;28:1810 –7.
  367. Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38: 1728–33.
  368. Anderson RH, Weinberg PM. The clinical anatomy of transposition. Cardiol Young. 2005;15 Suppl 1:76–87.
  369. Chesler E, Korns ME, Edwards JE. Anomalies of the tricuspid valve, including pouches, resembling aneurysms of the membranous ventricu- lar septum. Am J Cardiol. 1968;21:661– 8.
  370. Jones RN, Niles NR. Spinnaker formation of sinus venosus valve. Case report of a fatal anomaly in a ten-year-old boy. Circulation. 1968;38: 468–73.
  371. Warnes CA, Maron BJ, Jones M, Roberts WC. Asymptomatic sinus of Valsalva aneurysm causing right ventricular outflow obstruction before and after rupture. Am J Cardiol. 1984;54:1383– 4.
  372. Mohanakrishnan L, Vijayakumar K, Sukumaran P, et al. Unruptured sinus of Valsalva aneurysm with right ventricular outflow obstruction. Asian Cardiovasc Thorac Ann. 2003;11:74–6.
  373. Das SK, Jahnkee EJ, Walker WJ. Aneurysm of the membranous septum with interventricular septal defect producing right ventricular outflow obstruction. Circulation. 1964;30:429 –33.
  374. Freedom RM, Li J, Yoo SJ. Late complications following the Fontan opera- tion. In: Gatzoulis MA, Webb GD, Daubeney PE, editors. Diagnosis and Management of Adult Congenital Heart Disease; London: Churchill Livingston, 2003:85–91.
  375. Freedom RM, Yoo SJ. The divided right ventricle. In: The Natural and Modified History of Congenital Heart Disease. Elmsford, NY: Futura, 2004:232–5.
  376. Laforest I, Dumesnil JG, Briand M, Cartier PC, Pibarot P. Hemodynamic performance at rest and during exercise after aortic valve replacement: comparison of pulmonary autografts versus aortic homografts. Circulation. 2002;106:I57–I62.
  377. Veldtman GR, Dearani JA, Warnes CA. Low pressure giant pulmonary artery aneurysms in the adult: natural history and management strate- gies. Heart. 2003;89:1067–70.
  378. Cheatham JP, Coe JY, Kugler JD, Fletcher SE, Tower AJ. Successful tran- scatheter perforation of the atretic pulmonary valve membrane in a new- born using the new Coe radiofrequency end hole catheter. Cathet Cardiovasc Diagn. 1998;45:162– 6.
  379. Driscoll DJ, Michels VV, Gersony WM, et al. Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary steno- sis, or ventricular septal defect. Circulation. 1993; 87(suppl II): I114 –20.
  380. Nora JJ, Nora AH. Recurrence risks in children having one parent with a congenital heart disease. Circulation. 1976;53:701–2.
  381. Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet. 1985;21:493–506.
  382. Noonan J. Noonan syndrome—then and now. Cardiol Young. 1999;9: 545–6.
  383. Tramboo NA, Iqbal K, Dar MA, Malik RA, Naikoo BA, Andrabi MA. Unusual dysmorphic features in five patients with Noonan’s syndrome: a brief review. J Paediatr Child Health. 2002;38:521–5.
  384. Fryns JP. The cardio-facio-cutaneous (CFC) syndrome and Robertsonian 15/22 translocation. Ann Genet. 1992;35:186–8.
  385. Chou TC, Knilans TK. Congenital heart disease in adults. In: lectrocardiog- raphy in Clinical Practice. Philadelphia: W. B. Saunders Co., 1996:296 –318.
  386. Chen JT, Robinson AE, Goodrich JK, Lester RG. Uneven distribution of pulmonary blood flow between left and right lungs in isolated valvular pulmonary stenosis. Am J Roentgenol Radium Ther Nucl Med. 1969; 107:343–50.
  387. Arai N, Matsumoto A, Nishikawa N, et al. Beta-blocker therapy improved symptoms and exercise capacity in a patient with dynamic intra-right ventricular obstruction: an atypical form of doublechambered right ven- tricle. J Am Soc Echocardiogr. 2001;14:650 –3.
  388. Silvilairat S, Cabalka AK, Cetta F, Hagler DJ, O’Leary PW. Outpatient echocardiographic assessment of complex pulmonary outflow stenosis: Doppler mean gradient is superior to the maximum instantaneous gradi- ent. J Am Soc Echocardiogr. 2005;18:1143– 8.
  389. Shirani J, Zafari AM, Roberts WC. Sudden death, right ventricular infarc- tion, and abnormal right ventricular intramural coronary arteries in iso- lated congenital valvular pulmonic stenosis. Am J Cardiol. 1993;72: 368–70.
  390. Kan JS, White RI Jr, Mitchell SE, Gardner TJ. Percutaneous balloon valvu- loplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. 1982;307:540 –2.
  391. Stanger P, Cassidy SC, Girod DA, Kan JS, Lababidi Z, Shapiro SR. Balloon pulmonary valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol. 1990;65: 775–83.
  392. Ben-Shachar G, Cohen MH, Sivakoff MC, Portman MA, Riemenschneider TA, Van Heeckeren DW. Development of infundibular obstruction after percutaneous pulmonary balloon valvuloplasty. J Am Coll Cardiol. 1985;5:754–6.
  393. Sellors T. Surgery of pulmonary stenosis: a case in which the pulmonary valve was successfully divided. Lancet. 1948;251:I:988 –9.
  394. Varco RL. Discussion of the paper “The surgical treatment of cardiac valvular stenosis,” Muller, William H., Jr. and Longmire, William P., Jr. Surgery 1951;50:29.
  395. McNamara DG, Latson LA. Long-term follow-up of patients with malfor- mations for which definitive surgical repair has been available for 25 years or more. Am J Cardiol. 1982;50:560–8.
  396. Fiane AE, Lindberg HL, Saatvedt K, Svennevig JL. Mechanical valve replacement in congenital heart disease. J Heart Valve Dis. 1996;5: 337–42.
  397. Dittrich S, Alexi-Meskishvili VV, Yankah AC, et al. Comparison of porcine xenografts and homografts for pulmonary valve replacement in children. Ann Thorac Surg. 2000;70:717–22.
  398. Corno AF, Qanadli SD, Sekarski N, et al. Bovine valved xenograft in pul- monary position: medium-term follow-up with excellent hemodynamics and freedom from calcification. Ann Thorac Surg. 2004;78: 1382–8.
  399. Carr-White GS, Kilner PJ, Hon JK, et al. Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross opera- tion. Circulation. 2001;104:I16 –I20.
  400. Jarrar M, Betbout F, Farhat MB, et al. Long-term invasive and noninvasive results of percutaneous balloon pulmonary valvuloplasty in children, adolescents, and adults. Am Heart J. 1999;138:950–4.
  401. Teupe CH, Burger W, Schrader R, Zeiher AM. Late (five to nine years) fol- low-up after balloon dilation of valvular pulmonary stenosis in adults. Am J Cardiol. 1997;80:240 –2.
  402. Sadr-Ameli MA, Sheikholeslami F, Firoozi I, Azarnik H. Late results of bal- loon pulmonary valvuloplasty in adults. Am J Cardiol. 1998;82: 398–400.
  403. McCrindle BW, Kan JS. Long-term results after balloon pulmonary valvu- loplasty. Circulation. 1991;83:1915–22.
  404. Rao PS, Thapar MK, Kutayli F. Causes of restenosis after balloon valvulo- plasty for valvular pulmonary stenosis. Am J Cardiol. 1988;62: 979–82.
  405. O’Connor BK, Beekman RH, Lindauer A, Rocchini A. Intermediate- term outcome after pulmonary balloon valvuloplasty: comparison with a matched surgical control group. J Am Coll Cardiol. 1992;20: 169 –73.
  406. Peterson C, Schilthuis JJ, Dodge-Khatami A, Hitchcock JF, Meijboom EJ, Bennink GB. Comparative long-term results of surgery versus balloon valvuloplasty for pulmonary valve stenosis in infants and children. Ann Thorac Surg. 2003;76:1078–82.
  407. Marantz PM, Huhta JC, Mullins CE, et al. Results of balloon valvuloplas- ty in typical and dysplastic pulmonary valve stenosis: Doppler echocar- diographic follow-up. J Am Coll Cardiol. 1988;12:476 –9.
  408. Masura J, Burch M, Deanfield JE, Sullivan ID. Five-year follow-up after balloon pulmonary valvuloplasty. J Am Coll Cardiol. 1993;21:132– 6.
  409. Gersony WM. Long-term follow-up of operated congenital heart disease. Cardiol Clin. 1989;7:915–23.
  410. Kanter KR, Budde JM, Parks WJ, et al. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann Thorac Surg. 2002;73:1801– 6.
  411. Earing MG, Connolly HM, Dearani JA, Ammash NM, Grogan M, Warnes CA. Long-term follow-up of patients after surgical treatment for isolated pulmonary valve stenosis. Mayo Clin Proc. 2005;80:871– 6.
  412. Dore A. Pulmonary stenosis. In: Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingstone, 2003: 299–303.
  413. Gutgesell HP, Gessner IH, Vetter VL, Yabek SM, Norton JB Jr. Recreational and occupational recommendations for young patients with heart disease. A statement for physicians by the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 1986; 74: 1195A–8A.
  414. McNamara DG, Bricker JT, Galioto FM Jr, Graham TP Jr, James FW, Rosenthal A. Cardiovascular abnormalities in the athlete: recommenda- tions regarding eligibility for competition. Task force I: congenital heart disease. J Am Coll Cardiol. 1985;6:1200–8.
  415. Milo S, Fiegel A, Shem-Tov A, Neufeld HN, Goor DA. Hour-glass deformity of the pulmonary valve: a third type of pulmonary valve stenosis. Br Heart J. 1988;60:128 –33.
  416. Arvidsson H, Carlsson E, Hartmann A Jr, Tsifutis A, Crawford C. Supravalvular stenoses of the pulmonary arteries. Report of eleven cases. Acta Radiol. 1961;56:466–80.
  417. Raff GW, Gaynor JW, Weinberg PM, Spray TL, Gleason M. Membranous subpulmonic stenosis associated with ventricular septal defect and aortic insufficiency. J Am Soc Echocardiogr. 2000;13:58–60.
  418. Hadchouel M. Alagille syndrome. Indian J Pediatr. 2002;69:815– 8.
  419. Kumar A, Stalker HJ, Williams CA. Concurrence of supravalvular aortic stenosis and peripheral pulmonary stenosis in three generations of a fam- ily: a form of arterial dysplasia. Am J Med Genet. 1993;45:739–42.
  420. Cormode EJ, Dawson M, Lowry RB. Keutel syndrome: clinical report and literature review. Am J Med Genet. 1986;24:289 –94.
  421. Freij BJ, South MA, Sever JL. Maternal rubella and the congenital rubel- la syndrome. Clin Perinatol. 1988;15:247–57.
  422. Cormode EJ, Dawson M, Lowry RB. Keutel syndrome: clinical report and literature review. Am J Med Genet. 1986;24:289 –94.
  423. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pul- monary hypertension. J Am Coll Cardiol. 2004;43:5S–12S.
  424. Lock JE, Castaneda-Zuniga WR, Fuhrman BP, Bass JL. Balloon dilation angioplasty of hypoplastic and stenotic pulmonary arteries. Circulation. 1983;67:962–7.
  425. O’Laughlin MP. Catheterization treatment of stenosis and hypoplasia of pulmonary arteries. Pediatr Cardiol. 1998;19:48 –56.
  426. Kreutzer J, Landzberg MJ, Preminger TJ, et al. Isolated peripheral pul- monary artery stenoses in the adult. Circulation. 1996;93:1417–23.
  427. Dogan OF, Demircin M, Ozkutlu S, Pasaoglu I. Surgical management of infants with isolated supravalvular pulmonary stenosis: case reports. Heart Surg Forum. 2006;9:E668 –E674.
  428. Gober V, Berdat P, Pavlovic M, Pfammatter JP, Carrel TP. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann Thorac Surg. 2005;79:625–31.
  429. Rosenhek R, Binder T, Maurer G, Baumgartner H. Normal values for Doppler echocardiographic assessment of heart valve prostheses. J Am Soc Echocardiogr. 2003;16:1116 –27.
  430. Lloyd TR, Marvin WJ Jr, Mahoney LT, Lauer RM. Balloon dilation valvuloplasty of bioprosthetic valves in extracardiac conduits. Am Heart J. 1987;114:268 –74.
  431. Shaffer KM, Mullins CE, Grifka RG, et al. Intravascular stents in congen- ital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol. 1998;31:661–7.
  432. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic con- duit with valve dysfunction. Lancet. 2000;356:1403–5.
  433. Powell AJ, Lock JE, Keane JF, Perry SB. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results. Circulation. 1995;92:3282– 8.
  434. Bonhoeffer P, Boudjemline Y, Qureshi SA, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol. 2002;39:1664 –9.
  435. Wong PC, Sanders SP, Jonas RA, et al. Pulmonary valve-moderator band distance and association with development of double-chambered right ventricle. Am J Cardiol. 1991;68:1681– 6.
  436. McElhinney DB, Goldmuntz. Double-chambered right ventricle. In: Gatzoulis MA, Webb GD, Daubeney PE, editors. Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingstone, 2003:305–11.
  437. Moran AM, Hornberger LK, Jonas RA, Keane JF. Development of a double- chambered right ventricle after repair of tetralogy of Fallot. J Am Coll Cardiol. 1998;31:1127–33.
  438. Pongiglione G, Freedom RM, Cook D, Rowe RD. Mechanism of acquired right ventricular outflow tract obstruction in patients with ventricular septal defect: an angiocardiographic study. Am J Cardiol. 1982;50:776–80.
  439. Oliver JM, Garrido A, Gonzalez A, et al. Rapid progression of midventricu- lar obstruction in adults with double-chambered right ventricle. J Thorac Cardiovasc Surg. 2003;126:711–7.
  440. Goitein KJ, Neches WH, Park SC, Mathews RA, Lenox CC, Zuberbuhler JR. Electrocardiogram in double chamber right ventricle. Am J Cardiol. 1980;45:604–8.
  441. Ibrahim T, Dennig K, Schwaiger M, Schomig A. Images in cardiovascular medicine. Assessment of double chamber right ventricle by magnetic res- onance imaging. Circulation. 2002;105:2692–3.
  442. Chandrashekhar YS, Anand IS, Wahi PL. Balloon dilatation of dou- blechamber right ventricle. Am Heart J. 1990;120:1234–6.
  443. Gibbs JL, Uzun O, Blackburn ME, Parsons JM, Dickinson DF. Right ven- tricular outflow stent implantation: an alternative to palliative surgical relief of infundibular pulmonary stenosis. Heart. 1997;77: 176–9.
  444. Park SJ, Lee CW, Hong MK, Song JK, Park SW, Kim JJ. Transcoronary alcohol ablation of infundibular hypertrophy in patients with idiopathic infundibular pulmonic stenosis. Am J Cardiol. 1997;80:1514–6.
  445. O’Laughlin MP, Slack MC, Grifka RG, Perry SB, Lock JE, Mullins CE. Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation. 1993;88:605–14.
  446. Hachiro Y, Takagi N, Koyanagi T, Morikawa M, Abe T. Repair of double- chambered right ventricle: surgical results and long-term follow-up. Ann Thorac Surg. 2001;72:1520 –2.
  447. Massin MM, Nitsch GB, Dabritz S, Seghaye MC, Messmer BJ, von Bernuth G. Growth of pulmonary artery after arterial switch operation for simple transposition of the great arteries. Eur J Pediatr. 1998;157: 95–100.
  448. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–85.
  449. Gupta D, Saxena A, Kothari SS, et al. Detection of coronary artery anom- alies in tetralogy of Fallot using a specific angiographic protocol. Am J Cardiol. 2001;87:241– 4, A9.
  450. Coutu M, Poirier NC, Dore A, Carrier M, Perrault LP. Late myocardial revascularization in patients with tetralogy of Fallot. Ann Thorac Surg. 2004;77:1454 –5.
  451. Wernovsky G, Sanders SP. Coronary artery anatomy and transposition of the great arteries. Coron Artery Dis. 1993;4:148 –57.
  452. Tanel RE, Wernovsky G, Landzberg MJ, Perry SB, Burke RP. Coronary artery abnormalities detected at cardiac catheterization following the arterial switch operation for transposition of the great arteries. Am J Cardiol. 1995;76:153–7.
  453. Hauser M, Bengel FM, Kuhn A, et al. Myocardial blood flow and flow reserve after coronary reimplantation in patients after arterial switch and Ross operation. Circulation. 2001;103:1875– 80.
  454. Legendre A, Losay J, Touchot-Kone A, et al. Coronary events after arterial switch operation for transposition of the great arteries. Circulation. 2003;108(suppl I):II186 –90.
  455. Hausdorf G, Kampmann C, Schneider M. Coronary angioplasty for coro- nary stenosis after the arterial switch procedure. Am J Cardiol. 1995;76:621–3.
  456. Abhaichand R, Morice MC, Bonnet D, Sidi D, Bonhoeffer P. Stent sup- ported angioplasty for coronary arterial stenosis following the arterial switch operation. Catheter Cardiovasc Interv. 2002;56:278–80.
  457. Raisky O, Bergoend E, Agnoletti G, et al. Late coronary artery lesions after neonatal arterial switch operation: results of surgical coronary revascu- larization. Eur J Cardiothorac Surg. 2007;31:894–8.
  458. Angelini P. Coronary artery anomalies: an entity in search of an identity. Circulation. 2007;115:1296 –305.
  459. Angelini P, Velasco JA, Flamm S. Coronary anomalies: incidence, patho- physiology, and clinical relevance. Circulation. 2002;105: 2449–54.
  460. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276:199 –204.
  461. Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with isolat- ed congenital coronary artery anomalies. J Am Coll Cardiol. 1992; 20:640 –7.
  462. Ropers D, Moshage W, Daniel WG, Jessl J, Gottwik M, Achenbach S. Visualization of coronary artery anomalies and their anatomic course by contrast-enhanced electron beam tomography and three-dimensional reconstruction. Am J Cardiol. 2001;87:193–7.
  463. McConnell MV, Ganz P, Selwyn AP, Li W, Edelman RR, Manning WJ. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation. 1995;92: 3158–62.
  464. Angelini P, Velasco JA, Ott D, Khoshnevis GR. Anomalous coronary artery arising from the opposite sinus: descriptive features and pathophysiolog- ic mechanisms, as documented by intravascular ultrasonography. J Invasive Cardiol. 2003;15:507–14.
  465. Doorey AJ, Pasquale MJ, Lally JF, Mintz GS, Marshall E, Ramos DA Six- month success of intracoronary stenting for anomalous coronary arteries associated with myocardial ischemia. Am J Cardiol. 2000;86: 580–2, A10.
  466. Fedoruk LM, Kern JA, Peeler BB, Kron IL. Anomalous origin of the right coronary artery: right internal thoracic artery to right coronary artery bypass is not the answer. J Thorac Cardiovasc Surg. 2007;133: 456–60.
  467. Davis JA, Cecchin F, Jones TK, Portman MA. Major coronary artery anom- alies in a pediatric population: incidence and clinical importance. J Am Coll Cardiol. 2001;37:593–7.
  468. Romp RL, Herlong JR, Landolfo CK, et al. Outcome of unroofing procedure for repair of anomalous aortic origin of left or right coronary artery. Ann Thorac Surg. 2003;76:589 –95.
  469. Frommelt PC, Frommelt MA, Tweddell JS, Jaquiss RD. Prospective echocardiographic diagnosis and surgical repair of anomalous origin of a coronary artery from the opposite sinus with an interarterial course. J Am Coll Cardiol. 2003;42:148 –54.
  470. Keith JD. The anomalous origin of the left coronary artery from the pul- monary artery. Br Heart J. 1959;21:149–61.
  471. Takeuchi S, Imamura H, Katsumoto K, et al. New surgical method for repair of anomalous left coronary artery from pulmonary artery. J Thorac Cardiovasc Surg. 1979;78:7–11.
  472. Stern H, Sauer U, Locher D, et al. Left ventricular function assessed with echocardiography and myocardial perfusion assessed with scintigraphy under dipyridamole stress in pediatric patients after repair for anomalous origin of the left coronary artery from the pulmonary artery. J Thorac Cardiovasc Surg. 1993;106:723–32.
  473. Finley JP, Howman-Giles R, Gilday DL, Olley PM, Rowe RD. Thallium-201 myocardial imaging in anomalous left coronary artery arising from the pulmonary artery. Applications before and after medical and surgical treatment. Am J Cardiol. 1978;42:675– 80.
  474. Seguchi M, Nakanishi T, Nakazawa M, et al. Myocardial perfusion after aortic implantation for anomalous origin of the left coronary artery from the pulmonary artery. Eur Heart J. 1990;11:213– 8.
  475. Shivalkar B, Borgers M, Daenen W, Gewillig M, Flameng W. ALCAPA syn- drome: an example of chronic myocardial hypoperfusion? J Am Coll Cardiol. 1994;23:772– 8.
  476. Dua R, Smith JA, Wilkinson JL, et al. Long-term follow-up after two coro- nary repair of anomalous left coronary artery from the pulmonary artery. J Card Surg. 1993;8:384 –90.
  477. Bogers AJ, Quaegebeur JM, Huysmans HA. The need for follow-up after surgical correction of anomalous left coronary artery arising from the pul- monary artery. J Cardiovasc Surg (Torino). 1988;29:339–42.
  478. Ohmoto Y, Hara K, Kuroda Y, Fukuda S, Tamura T. Stent placement in surgically reimplanted left main coronary artery in patient with anom- alous origin of left main coronary artery from pulmonary artery. Cathet Cardiovasc Diagn. 1997;42:48 –50.
  479. Kwok OH, Landzberg MJ, Kinlay S, Marcus KC, Rogers C. Percutaneous coronary intervention and subsequent endovascular beta-radiation brachytherapy in a 14-year-old with repaired anomalous left coronary artery from pulmonary artery. J Invasive Cardiol. 2001;13:494 –500.
  480. Purut CM, Sabiston DC Jr. Origin of the left coronary artery from the pul- monary artery in older adults. J Thorac Cardiovasc Surg. 1991;102: 566–70.
  481. Dodge-Khatami A, Mavroudis C, Backer CL. Anomalous origin of the left coronary artery from the pulmonary artery: collective review of surgical therapy. Ann Thorac Surg. 2002;74:946 –55.
  482. Wada AM, Willet SG, Bader D. Coronary vessel development: a unique form of vasculogenesis. Arterioscler Thromb Vasc Biol. 2003;23: 2138–45.
  483. Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients under- going coronary arteriography. Cathet Cardiovasc Diagn. 1990;21: 28–40.
  484. Mavroudis C, Backer CL, Rocchini AP, Muster AJ, Gevitz M. Coronary artery fistulas in infants and children: a surgical review and discussion of coil embolization. Ann Thorac Surg. 1997;63:1235– 42.
  485. Armsby LR, Keane JF, Sherwood MC, Forbess JM, Perry SB, Lock JE. Management of coronary artery fistulae. Patient selection and results of transcatheter closure. J Am Coll Cardiol. 2002;39:1026 –32.
  486. Galie N. Classification of patients with congenital systemic-to-pulmonary shunts associated with pulmonary arterial hypertension: current status and future directions. In: Pulmonary Arterial Hypertension Related to Congenital Heart Disease. Munich: Elsevier GmbH; 2006:11–7.
  487. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. BMJ. 1958;46:701–9.
  488. Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF. The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med. 2001;22:405–18.
  489. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pul- monary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533– 47.
  490. Saha A, Balakrishnan KG, Jaiswal PK, et al. Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol. 1994;45: 199–207.
  491. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. The Eisenmenger syndrome in adults. Ann Intern Med. 1998;128:745–55.
  492. Cantor WJ, Harrison DA, Moussadji JS, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol. 1999;84:677– 81.
  493. Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical cor- rection. Circulation. 1989;80:840 –5.
  494. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease–long-term follow-up and prediction of outcome after surgical correction. Circulation. 1987;76:1037– 42.
  495. Sondel PM, Tripp ME, Ganick DJ, Levy JM, Shahidi NT. Phlebotomy with iron therapy to correct the microcytic polycythemia of chronic hypoxia. Pediatrics. 1981;67:667–70.
  496. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation. 1993;87:1954 –9.
  497. Bowyer JJ, Busst CM, Denison DM, Shinebourne EA. Effect of long term oxygen treatment at home in children with pulmonary vascular disease. Br Heart J. 1986;55:385–90.
  498. Sandoval J, Aguirre JS, Pulido T, et al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med. 2001;164:1682–7.
  499. Trulock EP. Lung transplantation for primary pulmonary hypertension. Clin Chest Med. 2001;22:583–93.
  500. Rosove MH, Hocking WG, Harwig SS, Perloff JK. Studies of beta-throm- boglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease. Thromb Res. 1983; 29:225–35.
  501. McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med. 1999; 130:740 –3.
  502. Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003;91:632–5.
  503. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pul- monary hypertension. N Engl J Med. 2002;347:322–9.
  504. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intra- venous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334:296 –302.
  505. Simonneau G, Barst RJ, Galie N, et al. Continuous subcutaneous infu- sion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebocontrolled trial. Am J Respir Crit Care Med. 2002;165:800–4.
  506. Galie N, Humbert M, Vachiery JL, et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hyperten- sion: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2002;39:1496 –502.
  507. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002;346:896 –903.
  508. Batista RJ, Santos JL, Takeshita N, et al. Successful reversal of pulmonary hypertension in Eisenmenger complex. Arq Bras Cardiol. 1997;68: 279–80.
  509. Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114:48 –54.
  510. Jones P, Patel A. Eisenmenger’s syndrome and problems with anaesthe- sia. Br J Hosp Med. 1995;54:214.
  511. Khairy P, Landzberg MJ, Gatzoulis MA, et al. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a mul- ticenter study. Circulation. 2006;113:2391–7.
  512. Harrison DA, Harris L, Siu SC, et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol. 1997;30:1368 –73.
  513. Harrison DA, Siu SC, Hussain F, MacLoghlin CJ, Webb GD, Harris L. Sustained atrial arrhythmias in adults late after repair of tetralogy of Fallot. Am J Cardiol. 2001;87:584–8.
  514. Therrien J, Warnes C, Daliento L, et al. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the manage- ment of adults with congenital heart disease part III. Can J Cardiol. 2001;17:1135–58.
  515. Landzberg MJ, Murphy DJ Jr, Davidson WR Jr, et al. Task force 4: organi- zation of delivery systems for adults with congenital heart disease. J Am Coll Cardiol. 2001;37:1187–93.
  516. Davlouros PA, Kilner PJ, Hornung TS, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular mag- netic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002;40:2044 –52.
  517. van Straten A, Vliegen HW, Hazekamp MG, de Roos A. Right ventricular func- tion late after total repair of tetralogy of Fallot. Eur Radiol. 2005;15:702–7.
  518. Boxt LM, Lipton MJ, Kwong RY, Rybicki F, Clouse ME. Computed tomog- raphy for assessment of cardiac chambers, valves, myocardium and peri- cardium. Cardiol Clin. 2003;21:561– 85.
  519. Koch K, Oellig F, Oberholzer K, et al. Assessment of right ventricular func- tion by 16-detector-row CT: comparison with magnetic resonance imag- ing. Eur Radiol. 2005;15:312– 8.
  520. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve relplacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–8.
  521. Gentles TL, Lock JE, Perry SB. High pressure balloon angioplasty for branch pulmonary artery stenosis: early experience. J Am Coll Cardiol. 1993;22:867–72.
  522. Rome JJ, Mayer JE, Castaneda AR, Lock JE. Tetralogy of Fallot with pul- monary atresia. Rehabilitation of diminutive pulmonary arteries. Circulation. 1993;88:1691– 8.
  523. Agnoletti G, Boudjemline Y, Bonnet D, Sidi D, Vouhe P. Surgical reconstruc- tion of occluded pulmonary arteries in patients with congenital heart dis- ease: effects on pulmonary artery growth. Circulation. 2004;109:2314–8.
  524. McMahon CJ, El-Said HG, Grifka RG, Fraley JK, Nihill MR, Mullins CE. Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol. 2001;38:521– 6.
  525. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103:10 –3.
  526. Knauth AL, Lock JE, Perry SB, et al. Transcatheter device closure of con- genital and postoperative residual ventricular septal defects. Circulation. 2004;110:501–7.
  527. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78:361– 8.
  528. Wessel HU, Paul MH. Exercise studies in tetralogy of Fallot: a review. Pediatr Cardiol. 1999;20:39–47.
  529. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993; 329:593–9.
  530. Norgaard MA, Lauridsen P, Helvind M, Pettersson G. Twenty-tothirty- seven-year follow-up after repair for Tetralogy of Fallot. Eur J Cardiothorac Surg. 1999;16:125–30.
  531. Wolff GS, Rowland TW, Ellison RC. Surgically induced right undlebranch block with left anterior hemiblock. An ominous sign in postoperative tetralogy of Fallot. Circulation. 1972;46:587–94.
  532. Gillette PC, Yeoman MA, Mullins CE, McNamara DG. Sudden death after repair of tetralogy of Fallot. Electrocardiographic and electrophysiologic abnormalities. Circulation. 1977;56:566 –71.
  533. Deanfield JE, Ho SY, Anderson RH, McKenna WJ, Allwork SP, Hallidie- Smith KA. Late sudden death after repair of tetralogy of Fallot: a clinico- pathologic study. Circulation. 1983;67:626 –31.
  534. Horowitz LN, Vetter VL, Harken AH, Josephson ME. Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of fallot. Am J Cardiol. 1980;46:446 –52.
  535. Kugler JD, Pinsky WW, Cheatham JP, Hofschire PJ, Mooring PK, Fleming WH. Sustained ventricular tachycardia after repair of tetralogy of Fallot: new electrophysiologic findings. Am J Cardiol. 1983;51: 1137–4
  536. Dunnigan A, Pritzker MR, Benditt DG, Benson DW Jr. Life threatening ventricular tachycardias in late survivors of surgically corrected tetralogy of Fallot. Br Heart J. 1984;52:198 –206.
  537. Garson A Jr, Randall DC, Gillette PC, et al. Prevention of sudden death after repair of tetralogy of Fallot: treatment of ventricular arrhythmias. J Am Coll Cardiol. 1985;6:221–7.
  538. Zimmermann M, Friedli B, Adamec R, Oberhansli I. Ventricular late potentials and induced ventricular arrhythmias after surgical repair of tetralogy of Fallot. Am J Cardiol. 1991;67:873– 8.
  539. Downar E, Harris L, Kimber S, et al. Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative mapping studies. J Am Coll Cardiol. 1992;20:648 –55.
  540. Cullen S, Celermajer DS, Franklin RC, Hallidie-Smith KA, Deanfield JE. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study. J Am Coll Cardiol. 1994; 23:1151–5.
  541. Jonsson H, Ivert T, Brodin LA, Jonasson R. Late sudden deaths after repair of tetralogy of Fallot. Electrocardiographic findings associated with survival. Scand J Thorac Cardiovasc Surg. 1995;29:131–9.
  542. Balaji S, Lau YR, Case CL, Gillette PC. QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot. Am J Cardiol. 1997;80:160 –3.
  543. Berul CI, Hill SL, Geggel RL, et al. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol. 1997;8:1349 –56.
  544. Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy of Fallot. Am J Cardiol. 2001;87:1271–7.
  545. Hamada H, Terai M, Jibiki T, Nakamura T, Gatzoulis MA, Niwa K. Influence of early repair of tetralogy of fallot without an outflow patch on late arrhythmias and sudden death: a 27-year follow-up study following a uniform surgical approach. Cardiol Young. 2002;12:345–51.
  546. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventric- ular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. 2002;40: 1675–80.
  547. Dore A, Santagata P, Dubuc M, Mercier LA. Implantable cardioverter defibrillators in adults with congenital heart disease: a single center expe- rience. Pacing Clin Electrophysiol. 2004;27:47–51.
  548. Russo G, Folino AF, Mazzotti E, Rebellato L, Daliento L. Comparison between QRS duration at standard ECG and signal-averaging ECG for arrhythmic risk stratification after surgical repair of tetralogy of fallot. J Cardiovasc Electrophysiol. 2005;16:288 –92.
  549. Veldtman GR, Connolly HM, Grogan M, Ammash NM, Warnes CA. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol. 2004;44:174–80.
  550. Child JS. Echocardiographic evaluation of the adult with postoperative congenital heart disease. In: Otto CM, editor. The Practice of Clinical Echocardiography. Philadelphia: W. B. Saunders; 2002:901–21.
  551. Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol. 1997;29:194 –201.
  552. Ebenroth ES, Hurwitz RA, Cordes TM. Late onset of pulmonary hyperten- sion after successful Mustard surgery for d-transposition of the great arteries. Am J Cardiol. 2000;85:127–30, A10.
  553. Wilson NJ, Clarkson PM, Barratt-Boyes BG, et al. Long-term outcome after the mustard repair for simple transposition of the great arteries. 28-year follow-up. J Am Coll Cardiol. 1998;32:758–65.
  554. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Decline in ventricu- lar function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22–29 years). Eur Heart J. 2004;25:1264 –70.
  555. Puley G, Siu S, Connelly M, et al. Arrhythmia and survival in patients _18 years of age after the mustard procedure for complete transposition of the great arteries. Am J Cardiol. 1999;83:1080–4.
  556. Sarkar D, Bull C, Yates R, et al. Comparison of long-term outcomes of atri- al repair of simple transposition with implications for a late arterial switch strategy. Circulation. 1999;100:II176 –II181.
  557. Moons P, Gewillig M, Sluysmans T, et al. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart. 2004;90:307–13.
  558. Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9:838 – 47.
  559. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Dopplerderived myocardial performance index: correlation with simultaneous measure- ments of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169 –78.
  560. Vogel M, Cheung MM, Li J, et al. Noninvasive assessment of left ventricular force-frequency relationships using tissue Doppler-derived isovolumic accel- eration: validation in an animal model. Circulation. 2003; 107:1647–52.
  561. Vogel M, Derrick G, White PA, et al. Systemic ventricular function in patients with transposition of the great arteries after atrial repair: a tis- sue Doppler and conductance catheter study. J Am Coll Cardiol. 2004;43: 100–6.
  562. Lissin LW, Li W, Murphy DJ Jr, et al. Comparison of transthoracic echocardio- graphy versus cardiovascular magnetic resonance imaging for the assess- ment of ventricular function in adults after atrial switch procedures for com- plete transposition of the great arteries. Am J Cardiol. 2004;93:654 –7.
  563. Hornung TS, Anagnostopoulos C, Bhardwaj P, et al. Comparison of equilibri- um radionuclide ventriculography with cardiovascular magnetic resonance for assessing the systemic right ventricle after Mustard or Senning procedures for complete transposition of the great arteries. Am J Cardiol. 2003;92:640 –3.
  564. Culbert EL, Ashburn DA, Cullen-Dean G, et al. Quality of life of children after repair of transposition of the great arteries. Circulation. 2003; 108:857– 62.
  565. Losay J, Hougen TJ. Treatment of transposition of the great arteries. Curr Opin Cardiol. 1997;12:84 –90.
  566. Losay J, Touchot A, Serraf A, et al. Late outcome after arterial switch opera- tion for transposition of the great arteries. Circulation. 2001;104: I121–I126.
  567. Schwartz ML, Gauvreau K, del NP, Mayer JE, Colan SD. Long-term pre- dictors of aortic root dilation and aortic regurgitation after arterial switch operation. Circulation. 2004;110:II128 –32.
  568. Formigari R, Toscano A, Giardini A, et al. Prevalence and predictors of neoaortic regurgitation after arterial switch operation for transposition of the great arteries. J Thorac Cardiovasc Surg. 2003;126:1753–9.
  569. Pasquali SK, Hasselblad V, Li JS, Kong DF, Sanders SP. Coronary artery pattern and outcome of arterial switch operation for transposition of the great arteries: a meta-analysis. Circulation. 2002;106:2575– 80.
  570. Hechter SJ, Fredriksen PM, Liu P, et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol. 2001; 87:660 –3, A11.
  571. Robinson B, Heise CT, Moore JW, Anella J, Sokoloski M, Eshaghpour E. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol. 2002; 23:618 –23.
  572. Lester SJ, McElhinney DB, Viloria E, et al. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol. 2001; 88:1314–6.
  573. Carrel T, Pfammatter JP. Complete transposition of the great arteries: sur- gical concepts for patients with systemic right ventricular failure following intraatrial repair. Thorac Cardiovasc Surg. 2000;48:224 –7.
  574. Coady MA, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA. Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg. 1999;67:1922– 6.
  575. Oechslin E, Jenni R. 40 years after the first atrial switch procedure in patients with transposition of the great arteries: long-term results in Toronto and Zurich. Thorac Cardiovasc Surg. 2000;48:233–7.
  576. Hutter PA, Kreb DL, Mantel SF, Hitchcock JF, Meijboom EJ, Bennink GB. Twenty-five years’ experience with the arterial switch operation. J Thorac Cardiovasc Surg. 2002;124:790 –7.
  577. Gandhi SK, Pigula FA, Siewers RD. Successful late reintervention after the arterial switch procedure. Ann Thorac Surg. 2002;73:88 –93.
  578. Poirier NC, Mee RB. Left ventricular reconditioning and anatomical cor- rection for systemic right ventricular dysfunction. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2000;3:198 –215.
  579. Prifti E, Bonacchi M, Luisi SV, Vanini V. Coronary revascularization after arterial switch operation. Eur J Cardiothorac Surg. 2002;21:111–3.
  580. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, et al. Cardiac trans- plantation after the Fontan or Glenn procedure. J Am Coll Cardiol. 2004;44:2065–72.
  581. Kammeraad JA, van Deurzen CH, Sreeram N, et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44:1095–102.
  582. Collins KK, Love BA, Walsh EP, Saul JP, Epstein MR, Triedman JK. Location of acutely successful radiofrequency catheter ablation of intraa- trial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000;86:969 –74.
  583. Rhodes LA, Wernovsky G, Keane JF, et al. Arrhythmias and intracardiac conduction after the arterial switch operation. J Thorac Cardiovasc Surg. 1995;109:303–10.
  584. Guedes A, Mercier LA, Leduc L, Berube L, Marcotte F, Dore A. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol. 2004;44: 433–7.
  585. Allwork SP, Bentall HH, Becker AE, et al. Congenitally corrected transposition of the great arteries: morphologic study of 32 cases. Am J Cardiol. 1976;38:910 –23.
  586. Warnes CA. Congenitally corrected transposition: the uncorrected mis- nomer. J Am Coll Cardiol. 1996;27:1244 –5.
  587. Schiebler GL, Edwards JE, Burchell HB, Dushane JW, Ongley PA, Wood EH. Congenital corrected transposition of the great vessels: a study of 33 cases. Pediatrics. 1961;(suppl):849–88.
  588. Dabizzi RP, Barletta GA, Caprioli G, Baldrighi G, Baldrighi V. Coronary artery anatomy in corrected transposition of the great arteries. J Am Coll Cardiol. 1988;12:486 –91.
  589. Anderson RH. Coronary artery patterns in complete transposition. Thorax. 1978;33:825.
  590. Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atri- oventricular block in patients with atrioventricular discordance. Circulation. 1983;67:1374 –7.
  591. Bharati S, McCue CM, Tingelstad JB, Mantakas M, Shiel F, Lev M. Lack of connection between the atria and the peripheral conduction system in a case of corrected transposition with congenital atrioventricular block. Am J Cardiol. 1978;42:147–53.
  592. Friedberg DZ, Nadas AS. Clinical profile of patients with congenital cor- rected transposition of the great arteries. A study of 60 cases. N Engl J Med. 1970;282:1053–9.
  593. Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Tajik AJ, Danielson GK. Outcome of the unoperated adult who presents with con- genitally corrected transposition of the great arteries. J Am Coll Cardiol. 2002;40:285–90.
  594. Prieto LR, Hordof AJ, Secic M, Rosenbaum MS, Gersony WM. Progressive tricuspid valve disease in patients with congenitally corrected transposi- tion of the great arteries. Circulation. 1998;98:997–1005.
  595. Lundstrom U, Bull C, Wyse RK, Somerville J. The natural and “unnatural” his- tory of congenitally corrected transposition. Am J Cardiol. 1990;65:1222–9.
  596. Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in con- genitally corrected transposition of the great arteries: a multiinstitutional study. J Am Coll Cardiol. 2000;36:255– 61.
  597. Ismat FA, Baldwin HS, Karl TR, Weinberg PM. Coronary anatomy in con- genitally corrected transposition of the great arteries. Int J Cardiol. 2002;86:207–16.
  598. Hornung TS, Bernard EJ, Jaeggi ET, Howman-Giles RB, Celermajer DS, Hawker RE. Myocardial perfusion defects and associated systemic ven- tricular dysfunction in congenitally corrected transposition of the great arteries. Heart. 1998;80:322– 6.
  599. Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol. 1996;27:1238–43.
  600. Warnes CA. Transposition of the great arteries. Circulation. 2006;114: 2699–709.
  601. Silverman NH, Gerlis LM, Horowitz ES, Ho SY, Neches WH, Anderson RH. Pathologic elucidation of the echocardiographic features of Ebstein’s mal- formation of the morphologically tricuspid valve in discordant atrioven- tricular connections. Am J Cardiol. 1995;76:1277– 83.
  602. Dore A, Houde C, Chan KL, et al. Angiotensin receptor blockade and exer- cise capacity in adults with systemic right ventricles: a multicenter, ran- domized, placebo-controlled clinical trial. Circulation. 2005;112: 2411–6.
  603. van Son JA, Danielson GK, Huhta JC, et al. Late results of systemic atri- oventricular valve replacement in corrected transposition. J Thorac Cardiovasc Surg. 1995;109:642–52.
  604. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol. 2005;46:1– 8.
  605. Voskuil M, Hazekamp MG, Kroft LJ, et al. Postsurgical course of patients with congenitally corrected transposition of the great arteries. Am J Cardiol. 1999;83:558–62.
  606. Biliciler-Denktas G, Feldt RH, Connolly HM, Weaver AL, Puga FJ, Danielson GK. Early and late results of operations for defects associated with correct- ed transposition and other anomalies with atrioventricular discordance in a pediatric population. J Thorac Cardiovasc Surg. 2001; 122:234–41.
  607. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with con- genitally corrected transposition of great arteries. J Am Coll Cardiol. 1999;33:1692–5.
  608. Therrien J, Barnes I, Somerville J. Outcome of pregnancy in patients with congen- itally corrected transposition of the great arteries. Am J Cardiol. 1999;84:820–4.
  609. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. Second of two parts. N Engl J Med. 2000;342:334–42.
  610. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol. 2003;92:182–7.
  611. Perloff JK. Clinical Recognition of Congenital Heart Disease. 5th ed. Philadelphia, Pa: Saunders; 2003.
  612. Yetman AT, Freedom RM, McCrindle BW. Outcome in cyanotic neonates with Ebstein’s anomaly. Am J Cardiol. 1998;81:749 –54.
  613. Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK, Deanfield JE. Outcome in neonates with Ebstein’s anomaly. J Am Coll Cardiol. 1992;19:1041– 6.
  614. Seward JB, Tajik AJ, Feist DJ, Smith HC. Ebstein’s anomaly in an 85-year- old man. Mayo Clin Proc. 1979;54:193– 6.
  615. Celermajer DS, Bull C, Till JA, et al. Ebstein’s anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol. 1994;23:170–6.
  616. MacLellan-Tobert SG, Driscoll DJ, Mottram CD, et al. Exercise tolerance in patients with Ebstein’s anomaly. J Am Coll Cardiol. 1997;29: 1615–22.
  617. Tworetzky W, McElhinney DB, Brook MM, Reddy VM, Hanley FL, Silverman NH. Echocardiographic diagnosis alone for the complete repair of major congenital heart defects. J Am Coll Cardiol. 1999;33: 228–33.
  618. Sreeram N, Sutherland GR, Geuskens R, et al. The role of transoe- sophageal echocardiography in adolescents and adults with congenital heart defects. Eur Heart J. 1991;12:231– 40.
  619. Randolph GR, Hagler DJ, Connolly HM, et al. Intraoperative trans- esophageal echocardiography during surgery for congenital heart defects. J Thorac Cardiovasc Surg. 2002;124:1176–82.
  620. Simpson IA, Sahn DJ. Adult congenital heart disease: use of transtho- racic echocardiography versus magnetic resonance imaging scanning. Am J Card Imaging. 1995;9:29 –37.
  621. Hartnell GG, Cohen MC, Meier RA, Finn JP. Magnetic resonance angiog- raphy demonstration of congenital heart disease in adults. Clin Radiol. 1996;51:851–7.
  622. Eustace S, Kruskal JB, Hartnell GG. Ebstein’s anomaly presenting in adulthood: the role of cine magnetic resonance imaging in diagnosis. Clin Radiol. 1994;49:690 –2.
  623. Ammash NM, Warnes CA, Connolly HM, Danielson GK, Seward JB. Mimics of Ebstein’s anomaly. Am Heart J. 1997;134:508 –13.
  624. Smith WM, Gallagher JJ, Kerr CR, et al. The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein’s anomaly of the tricuspid valve. Am J Cardiol. 1982;49: 1223–34.
  625. Oh JK, Holmes DR Jr, Hayes DL, Porter CB, Danielson GK. Cardiac arrhythmias in patients with surgical repair of Ebstein’s anomaly. J Am Coll Cardiol. 1985;6:1351–7.
  626. Kiziltan HT, Theodoro DA, Warnes CA, O’Leary PW, Anderson BJ, Danielson GK. Late results of bioprosthetic tricuspid valve replacement in Ebstein’s anomaly. Ann Thorac Surg. 1998;66:1539–45.
  627. Driscoll DJ, Mottram CD, Danielson GK. Spectrum of exercise intolerance in 45 patients with Ebstein’s anomaly and observations on exercise toler- ance in 11 patients after surgical repair. J Am Coll Cardiol. 1988;11:831– 6.
  628. Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23:1194–8.
  629. Gatzoulis MA, Webb GD, Daubney PEF. Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingston, 2003.
  630. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971; 26:240–8.
  631. Mavroudis C. Venous shunts and the Fontan circulation in adult congeni- tal heart disease. In: Gatzoulis MA, editor. Diagnosis and Management of Adult Congenital Heart Disease. London: Churchill Livingston, 2003:79–83.
  632. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connec- tion: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience. J Thorac Cardiovasc Surg. 1988;96:682–95
  633. Stamm C, Friehs I, Mayer JE Jr, et al. Long-term results of the lateral tun- nel Fontan operation. J Thorac Cardiovasc Surg. 2001;121:28–41.
  634. Marcelletti C, Corno A, Giannico S, Marino B. Inferior vena cava- pul- monary artery extracardiac conduit. A new form of right heart bypass. J Thorac Cardiovasc Surg. 1990;100:228 –32.
  635. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Proteinlosing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg. 1998;115: 1063–73.
  636. Costello JM, Steinhorn D, McColley S, Gerber ME, Kumar SP. Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activa- tor: a case report and review of the literature. Pediatrics. 2002; 109: e67.
  637. Mavroudis C, Deal BJ, Backer CL, et al. J. Maxwell Chamberlain Memorial Paper for congenital heart surgery. 111 Fontan conversions with arrhythmia surgery: surgical lessons and outcomes. Ann Thorac Surg. 2007; 84:1457– 65.
  638. Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoblation. J Thorac Cardiovasc Surg. 1998;115:547–56.
  639. Marcelletti CF, Hanley FL, Mavroudis C, et al. Revision of previous Fontan connections to total extracardiac cavopulmonary anastomosis: A multi- center experience. J Thorac Cardiovasc Surg. 2000;119:340–6.
  640. Gamba A, Merlo M, Fiocchi R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg. 2004;127: 555–62.
  641. Cecchin F, Johnsrude CL, Perry JC, Friedman RA. Effect of age and surgi- cal technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol. 1995;76:386 –91.
  642. Mandapati R, Walsh EP, Triedman JK. Pericaval and periannular intraa- trial reentrant tachycardias in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2003;14:119 –25.
  643. Rhodes LA, Walsh EP, Saul JP. Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J. 1995;130:323–7.
  644. Feltes TF, Friedman RA. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. J Am Coll Cardiol. 1994;24:1365–70.
  645. Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 1996;28:763–7.
  646. Hoare JV, Radford D. Pregnancy after Fontan repair of complex congenital heart disease. Aust N Z J Obstet Gynaecol. 2001;41:464–8.
  647. Hoffman J. I., Kaplan S., Liberthson R. R. Prevalence of congenital heart disease. //Am Heart J. 2004:147:425-439.
  648. Knowles R, Griebsch I, Dezateux C, Brown J. C. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. // Health Technology Assessment 2005; Vol. 9: No. 44
  649. Office for National Statistics. Death registrations in England and Wales, 2002: causes. // Health Stat Q2003;18:57–64.
  650. Marelli A. J., Mackie A. S., Ittu R. I. et al. Congenital Heart Disease in the General Population: Changing Prevalence and Age Distribution. // Circulation 2007; 115;163-172.
  651. Reinhard W, Hengstenberg F. C. Grown-up congenital heart disease: a ‘problem’ to take care of. // European Heart Journal (2005) 26, 8-10.
  652. Swan, L., Hillis, W. S. Exercise prescription in adults with congenital heart disease: A long way to go. // Heart, 2001, 83(6), 685-687.
  653. Simko, L. C., McGinnis, K. A. (). Quality of life experienced by adults with congenital heart disease. // AACN Clinical Issues, 2003- 14(1), 42-53.
  654. Lane, D. A., Lip, G. Y. H., & Millane, T. A. Quality of life in adults with con- genital heart disease. // Heart, 2002, 88, 71-75
  655. Kamphuis, M., Vogels, T., Ottenkamp, J. van der Wall, E. E., Verloove- Vanhorick, S. P. & Vliegen, H. W. Employment in adults with congenital heart disease. // Archives of Pediatric and Adolescent Medicine, 2002, 156(11), 1143-1148.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

Список зарубежной литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава

Table of contents

Данный блок поддерживает скрол*